Fluid collection devices, systems, and methods

Information

  • Patent Grant
  • 11938053
  • Patent Number
    11,938,053
  • Date Filed
    Monday, April 29, 2019
    5 years ago
  • Date Issued
    Tuesday, March 26, 2024
    2 months ago
Abstract
Examples relate to systems, devices, and methods for attaching a fluid collection device to a user or removing fluid collected from a user in the e fluid collection device using a vacuum source operably coupled thereto. The fluid collection devices include urine collection devices shaped to complement the female anatomy near the urethra, attach to the user with one or more flanges, and the vacuum source is operably coupled to the fluid collection device via one or more sections of conduit.
Description
BACKGROUND

An individual may have limited or impaired mobility such that typical urination processes are challenging or impossible. For example, the individual may have surgery or a disability that impairs mobility. In another example, the individual may have restricted travel conditions such as those experience by pilots, drivers, and workers in hazardous areas. Additionally, fluid collection from the individual may be needed for monitoring purposes or clinical testing.


Bed pans and urinary catheters, such as a Foley catheter, can be used to address some of these circumstances. However, bed pans and urinary catheters have several problems associated therewith. For example, bed pans can be prone to discomfort, spills, and other hygiene issues. Urinary catheters be can be uncomfortable, painful, and can cause urinary tract infections.


Thus, users and manufacturers of fluid collection devices continue to seek new and improved devices, systems, and methods to collect urine.


SUMMARY

Embodiments disclosed herein are related to devices, systems, and methods of using fluid collection devices. In an embodiment, a fluid collection device is disclosed. The fluid collection device includes a fluid collection member. The fluid collection member includes a fluid impermeable barrier at least partially defining a chamber, the fluid impermeable barrier also defining an opening extending therethrough, the opening configured to be positioned adjacent to a female urethra or have a male urethra positioned therethrough. The fluid collection member includes wicking material disposed at least partially within the chamber. The fluid collection member includes a conduit disposed within the chamber, the conduit including an inlet positioned within the fluid collection device and an outlet configured to be in fluid communication with a portable vacuum source. The fluid collection device includes at least one flange extending outwardly from the fluid collection member, the at least one flange including an adhesive member thereon.


In an embodiment, a fluid collection system is disclosed. The fluid collection system includes a fluid storage container configured to hold a fluid. The fluid collection system includes a fluid collection device in fluid communication with the fluid storage container. The fluid collection device includes a fluid collection member. The fluid collection member includes a fluid impermeable barrier at least partially defining a chamber, the fluid impermeable barrier also defining an opening extending therethrough, the opening configured to be positioned adjacent to a female urethra or have a male urethra positioned therethrough. The fluid collection member includes a wicking material disposed at least partially within the chamber. The fluid collection member includes a conduit disposed within the chamber, the conduit including an inlet positioned within the fluid collection device and an outlet configured to be in fluid communication with a portable vacuum source. The fluid collection device includes at least one flange extending outwardly from the fluid collection member, the at least one flange including an adhesive member thereon. The fluid collection system includes a vacuum source in fluid communication with one or more of the fluid storage container or the fluid collection device, the vacuum source configured to draw fluid from the fluid collection device.


In an embodiment, a method to collect fluid is disclosed. The method includes positioning an opening of a fluid collection device adjacent to a female urethra or around a male urethra of a user, the opening defined by a fluid impermeable barrier of the fluid collection device. The method includes positioning securing the fluid collection device to the user. The method includes positioning receiving fluid from the female urethra or male urethra into a chamber of the fluid collection device, the chamber of the fluid collection device at least partially defined by the fluid impermeable barrier.


Features from any of the disclosed embodiments may be used in combination with one another, without limitation. In addition, other features and advantages of the present disclosure will become apparent to those of ordinary skill in the art through consideration of the following detailed description and the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

The drawings illustrate several embodiments of the present disclosure, wherein identical reference numerals refer to identical or similar elements or features in different views or embodiments shown in the drawings.



FIG. 1 is a block diagram of a system for fluid collection, according to an embodiment.



FIG. 2A is an isometric view of a fluid collection device, according to an embodiment.



FIG. 2B is a front view of a user with the fluid collection device of FIG. 2A positioned for use, according to an embodiment.



FIGS. 3-5 are schematic cross-sectional views of fluid collection devices taken along the plane A-A of FIG. 2A, according to embodiments.



FIGS. 6-8 are schematic cross-sectional views of fluid collection devices taken along the plane B-B of FIG. 2A, according to embodiments.



FIG. 9A is an isometric view of a fluid collection device, according to an embodiment.



FIG. 9B is schematic cross-sectional view of the fluid collection device taken along the plane C-C of FIG. 9A, according to an embodiment.



FIG. 10 is a flow diagram of a method to collect fluid, according to an embodiment.





DETAILED DESCRIPTION

Embodiments disclosed herein are related to devices, systems, and methods of using fluid collection devices and systems. The devices, systems, and methods of using fluid collection devices and systems include at least one flange extending from the fluid collection device where the at least one flange is positioned to attach to the skin of a user and align the fluid collection device with one or more anatomical structures of the user (e.g., urethra). The devices, systems, and methods of using fluid collection devices and systems include a portable vacuum source to remove urine from the fluid collection device. The portable vacuum source may allow for portable usage of the systems and methods herein such as in non-hospital environments.


In an embodiment, a fluid collection device includes a fluid impermeable barrier that at least partially defines a chamber. The fluid impermeable barrier also defines an opening extending therethrough that is configured to be positioned adjacent to a female urethra or have a male urethra positioned therethrough. The fluid collection device also includes a tube having a channel extending between an inlet and outlet thereof. The inlet is configured to be coupled to a suction source and the outlet is configured to be fluidly coupled to (e.g., in fluid communication with) a fluid storage (vessel or container). The outlet is positioned downstream from the inlet. The channel also defines at least one aperture therein that fluidly couples an interior of the channel to the rest of the chamber.


The fluid collection devices disclosed herein are configured to collect fluid(s) from an individual. The fluid(s) collected by the fluid collection devices can include urine. The fluid(s) collected by the fluid collection devices can also include at least one of vagina discharge, penile discharge, reproductive fluids, blood, sweat, or other bodily fluids.


The fluid collection devices disclosed herein are configured to be used in fluid collection systems. The fluid collection systems disclosed herein include a gas source. Systems that include a gas source can, in some embodiments, resolve several problems associated with systems that include a vacuum source. For example, a system that includes a vacuum source draws fluid(s) towards the vacuum source and deposits most of the fluid(s) in a fluid storage container before the fluid(s) can reach the vacuum source. However, a small quantity of fluid(s) (e.g., vapor from the fluid) can still reach the vacuum source, which can contaminate and/or damage (e.g., rust) the vacuum source. Additionally, a large quantity of the fluid(s) can reach the vacuum source when the fluid storage container is substantially full. However, a system that includes a gas source moves the fluid(s) away from the gas source, thereby preventing contamination and/or damage. For example, a gas source may be used to create a vacuum by flowing a gas past a connected end of the conduit at a perpendicular or oblique angle to the conduit to create a vacuum in the conduit. The fluids are pulled up the conduit and into the gas flow in the direction of the gas flow, which is away from the gas source. In another embodiment, systems that include a vacuum source cannot be used in environments that do not include an available vacuum source (e.g., the environment does not include a vacuum source or the vacuum source is being used). As such, systems that include a gas source can be used in environments that do not include an available vacuum source. A liquid source can be used to create and implement a vacuum in the same way as the gas source. The vacuum source or gas source can be utilized with any of the devices or systems disclosed herein to remove a fluid therefrom.



FIG. 1 is a block diagram of a system 10 for fluid collection, according to an embodiment. The system 10 includes a fluid collection device 12, a fluid storage container 14, and a vacuum source 16. The fluid collection device 12, the fluid storage container 14, and the vacuum source 16 may be in fluid communication with (e.g., fluidly coupled to) each other via one or more conduits 17. For example, fluid collection device 12 may be in fluid communication with one or more of the fluid storage container 14 or the vacuum source via the conduit 17. Fluid (e.g., urine or other bodily fluids) collected in the fluid collection device 12 may be removed from the fluid collection device 12 via the conduit 17 which protrudes into an interior region of the fluid collection device 12. For example, a first open end of the conduit 17 may extend into the fluid collection device 12 to a reservoir therein. The second open end of the conduit 17 may extend into the fluid storage container 14 or the vacuum source 16. The suction force may be introduced into the interior region of the fluid collection device 12 via the first open end of the conduit 17 responsive to a suction (e.g., vacuum) force applied at the second end of the conduit 17. The suction force may be applied to the second open end of the conduit 17 by the vacuum source 16 either directly or indirectly.


The suction force may be applied indirectly via the fluid storage container 14. For example, the second open end of the conduit 17 may be disposed within the fluid storage container 14 and an additional conduit 17 may extend from the fluid storage container 14 to the vacuum source 16. Accordingly, the vacuum source 16 may apply suction to the fluid collection device 12 via the fluid storage container 14. The suction force may be applied directly via the fluid storage container 14. For example, the second open end of the conduit 17 may be disposed within the vacuum source 16. An additional conduit 17 may extend from the vacuum source 16 to a point outside of the fluid collection device 12, such as to the fluid storage container 14. In such examples, the vacuum source 16 may be disposed between the fluid collection device 12 and the fluid storage container 14.


The fluid collection device 12 may be shaped and sized to be positioned adjacent to a female urethra. For example and as described in more detail below, the fluid collection device 12 may include a fluid collection member and at least one flange positioned and equipped to attach to the skin of a user and align the fluid collection member in a selected portion of the anatomy of the user (e.g., adjacent to or on the urethra or vagina). For example, the at least one flange may include an adhesive for reversibly attaching to the skin of the user and may be positioned on the fluid collection member to align an opening of the fluid collection member with the vagina (e.g., on or over the urethra or between the labia) of a female user.


The fluid collection member of the fluid collection device 12 may include a fluid impermeable barrier at least partially defining a chamber (e.g., interior region of the fluid collection device member) of the fluid collection device 12. The fluid impermeable barrier also defines an opening extending therethrough from the external environment. The opening may be positioned on the fluid collection member to be aligned adjacent to a female urethra. The fluid collection member of the fluid collection device 12 may include a fluid permeable membrane disposed within the fluid impermeable barrier. The fluid collection member of the fluid collection device 12 may include a fluid permeable support disposed within the fluid permeable membrane. The conduit 17 may extend into the fluid collection device 12 at a first end region, through one or more of the fluid impermeable barrier, fluid permeable membrane, or the fluid permeable support to a second end region of the fluid collection member of the fluid collection device 12. Exemplary fluid collection devices for use with the systems and methods herein are described in more detail below.


In examples, the fluid storage container 14 may include a bag (e.g., drainage bag), a bottle or cup (e.g., collection jar), or any other enclosed container for storing bodily fluid(s) such as urine. In examples, the conduit 17 may extend from the fluid collection device 12 and attach to the fluid storage container 14 at a first point therein. An additional conduit 17 may attach to the fluid storage container 14 at a second point thereon and may extend and attach to the vacuum source 16. For example, the fluid storage container 14 may include a container in fluid communication with a first conduit section that is also in fluid communication with the fluid collection member of the fluid collection device 12. The container may be in fluid communication with a second section of the conduit 17 that is also in fluid communication with a vacuum source. In such examples, the vacuum source 16 may provide a vacuum/suction through the container to the fluid collection member to provide suction in the chamber of the fluid collection member. Accordingly, a vacuum (e.g., suction) may be drawn through fluid collection device 12 via the fluid storage container 14. As the fluid is drained from the chamber, the fluid may travel through the first section of conduit to the fluid storage container where it may be retained. Fluid, such as urine, may be drained from the fluid collection device 12 using the vacuum source 16.


In some examples, the vacuum source 16 may include a portable vacuum source. In examples, the portable vacuum source may be disposed in or on the fluid collection device 12. In such examples, the conduit 17 may extend from the fluid collection device and attach to the (portable) vacuum source 16 at a first point therein. An additional conduit 17 may attach to the vacuum source 16 at a second point thereon and may extend out of the fluid collection device 12, and may attach to the fluid storage container 14. Accordingly, a vacuum (e.g., suction) may be drawn through fluid collection device 12 via the fluid storage container 14.


The vacuum source 16 may include one or more of a vacuum line plumbed into patient care facility, a manual vacuum pump, and electric vacuum pump, a diaphragm pump, a centrifugal pump, a displacement pump, a magnetically driven pump, a peristaltic pump, or any pump configured to produce a vacuum. The vacuum source 16 may provide a vacuum or suction to remove fluid from the fluid collection member of the fluid collection device 12. In examples, the vacuum source 16 may be powered by one or more of a power cord (e.g., connected to a power socket), one or more batteries, or even manual power (e.g., a hand operated vacuum pump). In examples, the vacuum source 16 (e.g., portable vacuum source) may be sized and shaped to fit outside of, on, or within the fluid collection device 12. For example, the vacuum source 16 (e.g., portable vacuum source) may include one or more miniaturized pumps or one or more micro pumps. The vacuum sources 16 disclosed herein may include one or more of a switch, a button, a plug, a remote, or any other device suitable to activate the vacuum source 16. It should be understood that the vacuum sources 16 disclosed herein may provide a portable means of providing a suction or vacuum that allows use of the devices and systems herein outside of hospital or care facility environments where vacuum lines are plumbed into patient rooms or large (e.g., larger or heavier than a patient can readily carry) vacuum sources are located. For example, a portable vacuum source may be small and light enough to be carried by a user (e.g., patient) or aid (e.g., nurse) during transportation of the user.



FIG. 2A is an isometric view of a fluid collection device 100, according to an embodiment. The fluid collection device 100 includes a fluid collection member 101 and at least one flange 140 extending from the fluid collection member 101. In some examples, the fluid collection member 101 may be substantially cylindrical, ellipsoid, prismatic, or any other shape suitable for complementing or contouring to the vaginal region of a female subject. The fluid collection member 101 may include a fluid impermeable barrier 102, wicking material 115, and a conduit 108. The wicking material 115 may be disposed at least partially within the fluid impermeable barrier 102. The conduit 108 may be at least partially disposed with wicking material 115.


The fluid impermeable barrier 102 at least partially defines at least a portion of an outer surface of the fluid collection member 101. The fluid impermeable barrier 102 at least partially defines a chamber 104 therein (e.g., interior region of the fluid collection member 101) and an opening 106. The opening 106 is formed in and extends through the fluid impermeable barrier 102, thereby enabling fluid(s) to enter the chamber 104 from outside of the fluid collection member 101 of the fluid collection device 100. The opening 106 can be configured to be positioned adjacent to a female urethra, such as between the labia majora of a female user.


The fluid impermeable barrier 102 may also temporarily retain or store fluid(s) in the chamber 104. For example, the fluid impermeable barrier 102 can be formed of any suitable fluid impermeable materials, such as a fluid impermeable polymer (e.g., silicone, polypropylene, polyethylene, polyethylene terephthalate, polyurethane, a polycarbonate, polyvinyl chloride, latex, silicone, etc.), a metal film, another suitable material, or combinations thereof. As such, the fluid impermeable barrier 102 may prevent at least some of the fluid(s) from exiting the portions of the chamber 104 that are spaced from the opening 106.


In an embodiment, the fluid impermeable barrier 102 can be air permeable and fluid impermeable. In such an embodiment, the fluid impermeable barrier 102 can be formed of a hydrophobic material that defines a plurality of pores. In an example, one or more portions of at least an outer surface of the fluid impermeable barrier 102 can be formed from a soft and/or smooth material thereby reducing chafing of the skin of the user. The fluid impermeable barrier 102 may include markings thereon, such as one or more markings to aid a user in aligning the device 100 on the wearer. For example, a line on the fluid impermeable barrier 102 (e.g., opposite the opening 106) may allow a healthcare professional to align the opening 106 over the urethra of the wearer. In examples, the markings may include one or more of alignment guide or an orientation indicator, such as a stripe or hashes. Such markings may be positioned to align the device 100 to one or more anatomical features such as a pubic bone, etc.


The wicking material 115 may be disposed at least partially within the fluid impermeable barrier 102. The wicking material 115 may include permeable material designed to wick or allow fluid to pass therethrough. The permeable properties referred to herein can be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.” Such “wicking” may not include absorption into the wicking material. The wicking material 115 may collect the fluid that travels through the opening 106. The wicking material 115 may include more than one material, such as a plurality of materials. The plurality of materials may include a plurality of layers concentrically disposed within one another. The concentrically disposed layers of wicking materials may exhibit a gradient of wicking, such as where the innermost wicking material includes the greatest or least wicking ability of the plurality of materials.


In examples, the wicking material 115 may include one or more of a fluid permeable support (FIGS. 3-8) or a fluid permeable membrane 118. For example, the fluid collection member 101 of the fluid collection device 100 can include a fluid permeable membrane 118 disposed in the chamber 104. The fluid permeable membrane 118 can cover at least a portion (e.g., all) of the opening 106. The fluid permeable membrane 118 can be configured to wick any fluid away from the opening 106, thereby preventing the fluid from escaping the chamber 104. The fluid permeable membrane 118 can also wick the fluid generally towards an interior of the chamber 104, as discussed in more detail below. The fluid permeable membrane 118 can include any material that can wick the fluid. For example, the fluid permeable membrane 118 can include fabric, such as a gauze (e.g., a silk, linen, polyester, or cotton gauze), another soft fabric (e.g., jersey knit fabric or the like), or another smooth fabric (e.g., rayon, satin, or the like). In some examples, the fluid permeable membrane 118 can include an open cell foam. Forming the fluid permeable membrane 118 from gauze, soft fabric, and/or smooth fabric can reduce chafing caused by the fluid collection device 100.


The fluid collection device 100 can include a fluid permeable support 120 (FIGS. 3-8) disposed in the chamber 104. The fluid permeable support 120 may support the fluid permeable membrane 118 since the fluid permeable membrane 118 can be formed from a foldable, flimsy, or otherwise easily deformable material. For example, the fluid permeable support 120 can be positioned such that the fluid permeable membrane 118 is disposed between the fluid permeable support and the fluid impermeable barrier 102. As such, the fluid permeable support 120 can support and maintain the position of the fluid permeable membrane 118. The fluid permeable support 120 can be formed from any fluid permeable material that is less deformable than the fluid permeable membrane 118. For example, the fluid permeable support 120 can include a porous nylon structure or an open cell foam. In embodiments, the fluid permeable support can be omitted from the fluid collection device 100.


In some embodiments, the wicking material 115 (e.g., one or more of the fluid permeable membrane 118 or the fluid permeable support) can at least substantially completely fill portions of the chamber 104 that are not occupied by the conduit 108. For example, the wicking material 115 may fill the portions of the chamber 104 that are not occupied by the conduit 108. In some examples, the fluid permeable membrane 118 and the fluid permeable support may not substantially completely fill the portions of the chamber 104 that are not occupied by the conduit 108. In such examples, the fluid collection device 100 may include the reservoir (e.g., void space) disposed in the chamber 104. The reservoir may include a void space between the wicking material in the chamber 104 and the interior surface of the fluid impermeable barrier 102. At least some of the fluid absorbed by the wicking material 115 may drain out of the wicking material 115 and collect in the reservoir.


The fluid collection member 101 of the fluid collection device 100 may also include conduit 108 that is at least partially disposed in the chamber 104. The conduit 108 may include a flexible material such as plastic tubing (e.g., medical tubing). Such plastic tubing may include a thermoplastic elastomer, polyvinyl chloride, ethylene vinyl acetate, polytetrafluoroethylene, etc., tubing. In examples, the conduit 108 may include silicon or latex. The conduit 108 (e.g., a tube) includes an inlet at a first end region and an outlet at a second end region positioned downstream from the inlet. The conduit 108 places an interior region of the chamber 104 in fluid communication with one or more of the fluid storage container (FIG. 1) or the vacuum source (FIG. 1). The fluid may be removed from the chamber 104 via the conduit 108. As suction or vacuum force is applied or formed in the conduit 108 by the vacuum source (FIG. 1), the fluid in the chamber 104 may be drawn into the inlet and out of the fluid collection member 101 via the conduit 108.


In examples, the conduit 108 may be disposed in an innermost or gravimetrically low spot in the chamber 104. For example, the conduit 108 may extend far enough into the chamber 104 to position the inlet in a gravimetrically low spot of the chamber 104 (e.g., fluid reservoir within the interior of the fluid collection member 101).


The fluid collection member 101 and components thereof may be deformable (e.g., bendable) responsive to pressure applied thereto. For example, the fluid collection member 101 and the components thereof may bend to conform to the surface of the user, such as when disposed between a garment and the user. In examples, the fluid collection member 101 may bend when disposing proximate to the urethra (e.g., between the labia) when undergarments are pulled on over the fluid collection member 101.


The at least one flange 140 may extend from the fluid collection member 101. The at least one flange may include a flange body 142 and an adhesive member 144 disposed on the flange body 142. In some examples, the at least one flange 140 may include 2 or more flanges (e.g., 4 flanges). The at least one flange 140 may include a first flange body extending a first direction away from the fluid collection member 101 and a second flange body extending away from the fluid collection member 101 in a second direction, wherein the first and second directions are substantially opposite one another (e.g., at least 120° apart). The at least one flange 140 may extend along at least a portion of the longitudinal length of fluid collection member 101. For example, the at least one flange 140 may have a width, as viewed parallel to the plane B-B, of least 5% (e.g., at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, or less than 60%) of the longitudinal length of the fluid collection member 101. In examples, the width of the flange 140 may be at least 1 cm, such as 2 cm, 5 cm, 10 cm, 15 cm, 20 cm, 30 cm, or in a range between any combination of the foregoing. The flange 140 (e.g., flange body 142) may extend at least 1 cm away from the fluid collection member 101, such as 1 cm, 3 cm, 5 cm, 10 cm, 15 cm, 20 cm, 25 cm, 30 cm, or in a range between any combination of the foregoing, away from the fluid collection member 101.


In examples, the flange body 142 of the at least one flange 140 may be formed of the same material as the fluid impermeable barrier 102. In examples, the flange body 142 of the at least one flange 140 may be formed from one or more of cloth, paper, plastic, or any other material suitable for deforming responsive to pressure applied thereto and able to withstand moisture without breaking down. For example, the flange body 142 may be formed from thermoplastic elastomer, polyethylene, polyvinyl chloride, ethylene vinyl acetate, polytetrafluoroethylene, latex, silicon, fabric, woven cloth, etc. In examples, the conduit 108 may include silicon or latex. The flange body 142 of the at least one flange 140 may be flexible and may conform to manipulation or movement by a user. The flange body 142 may exhibit any of the dimensions disclosed above for the flange 140.


The flange body 142 may have the adhesive member 144 disposed thereon, such as at a distal portion thereof (e.g., distal from the fluid collection member 101). The adhesive member 144 may be affixed to the flange body 142 by mechanical means such as a staple(s), a clip, hook and loop fasteners, etc.; may be affixed by an adhesive; or may be integrally formed in the flange body 142. The adhesive member 144 may be positioned on the flange body 142 in a position effective to allow the adhesive to be applied to a garment of the skin of the user to maintain a position of the fluid collection member 101 with respect to one or more anatomical features (e.g., proximate to the female urethra or between the labia) of the user. For example, the adhesive member 144 may be positioned on the flange body 142 to allow the at least one flange(s) 140 to adhere to the inner thigh of a user and maintain a position of the associated fluid collection member 101 between the labia of the user 190. In examples, the adhesive member 144 may be flexible or otherwise configured to conform to the anatomical features of the user and accommodate movement of the user.



FIG. 2B is a front view of a user 190 with the fluid collection device 100 positioned for use, according to an embodiment. The user 190 may be a female and the fluid collection device 100 may be positioned for use (e.g., collecting urine or other bodily fluids from the vagina). For example, the flanges 140 may be disposed on the fluid collection member 101 in a position to locate the fluid collection member 101 between the labia 192 when the at least one flange 140 is adhered to the inner thigh 194 of the user 190. In examples, the at least one flange 140 can be adhered to the pubic region (e.g., lower abdominal region) of the user 190 to align the fluid collection member over the urethra of the user 190. In some examples, the at least one flange 140 can be adhered to the fabric of a garment worn by the user 190 (e.g., an undergarment). The conduit 108 may be in fluid communication with the fluid storage container or vacuum pump (not shown) to remove any collected fluid(s) from the fluid collection device 100.


Returning to FIG. 2A, the at least one flange body 142 may include the adhesive member 144 disposed thereon. For example, the adhesive member 144 may be facing upward on the flange body 142 (e.g., in the general direction of the fluid collection member 101). In some examples, the flange 140 may additional or alternatively include the adhesive member 144 facing downward on the flange body 142. In examples, the adhesive member 144 may be located on a distal portion of the flange body 142 (e.g., distal from the fluid collection member 101). In examples, the adhesive member 144 may cover at least 5% of the surface area of the flange body 142, such as 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or ranges between any combination of the foregoing, of the surface area of the flange body 142.


In examples, the adhesive member 144 may include a glue, contact adhesive, epoxy, hydrogel adhesive, tape, or other adhesive suitable for attaching the flange to skin or fabric. For example, the adhesive may include an acrylate (e.g., methacrylate or epoxy diacrylate) or any other adhesive suitable for use on bandages.


The cross-sectional profiles of the fluid collection devices disclosed herein may vary. For example, a longitudinal cross section is taken along the plane A-A and an axial cross section may be viewed along the plane B-B in FIG. 2A.



FIG. 3 is a schematic cross-sectional view of the fluid collection device 100 taken along the plane A-A of FIG. 2A, according to an embodiment. The fluid collection device 100 is an example of a female fluid collection device 100 sized, shaped, and otherwise configured to receive fluid(s) from a female user. The fluid collection device 100 includes the fluid collection member 101 and the at least one flange 140. The fluid collection member 101 includes the fluid impermeable barrier 102. The fluid impermeable barrier 102 at least partially defines the chamber 104 (e.g., interior region) and the opening 106. The opening 106 is formed in and extends through the fluid impermeable barrier 102, thereby enabling fluid(s) to enter the chamber 104 from outside of the fluid collection device 100. The opening 106 can be configured to be positioned adjacent to a female urethra. The opening 106 can be positioned on an upward facing portion of the fluid collection member 101 (e.g., region substantially opposite the flanges 140). The fluid collection device 100 also includes conduit 108 that is at least partially disposed in the chamber 104. The conduit 108 (e.g., a tube) includes an inlet 110 at a first end region and an outlet 112 at a second end region positioned downstream from the inlet 110. The conduit 108 places the chamber 104 in fluid communication with the fluid storage container (not shown) or the vacuum source (not shown).


In the illustrated embodiment, the conduit 108 is at least partially disposed in the chamber 104. For example, the conduit 108 may extend into the fluid impermeable barrier 102 from the first end region (e.g., proximate to the outlet 112) and may extend to the second end region (e.g., opposite the first end region) to a point proximate to the reservoir 122 such that the inlet 110 is in fluid communication with the reservoir 122. The fluid collected in the fluid collection member 101 may be removed from the interior region of the chamber 104 via the conduit 108. The conduit 108 may include a flexible material such as plastic tubing (e.g., medical tubing) as disclosed herein. In some examples, the conduit 108 may include one or more portions that are resilient, such as to by having one or more of a diameter or wall thickness that allows the conduit to be flexible.


The fluid collection member 101 may be positioned proximate to the female urethra (e.g., on or between the labia) and urine may enter the chamber 104 of the fluid collection member 101 via the opening 106. The fluid collection member 101 receives the fluid(s) into the chamber 104 via the opening 106. For example, the opening 106 can exhibit an elongated shape that is sized and positioned to extend from a first location below the urethral opening (e.g., at or near the anus or the vaginal opening) to a second location above the urethral opening (e.g., at or near the clitoris or the mons pubis). The opening 106 can exhibit an elongated shape since the space between the legs of a female is relatively small when the legs of the female of closed thereby only permitting the flow of the fluid(s) along a path that corresponds to the elongated shape of the opening 106. The longitudinal axis or dimension of the fluid collection device refers to the axis or dimension that is parallel to largest dimension of the device, such as axially along a cylindrical device as show in FIG. 2A. The opening 106 in the fluid impermeable barrier 102 can exhibit a width that is measured transverse to the longitudinal direction and may be at least about 10% of the circumference of the fluid collection member 101, such as about 25%, 30%, 40%, 50%, 60%, 75%, 85%, 100% or ranges between any combination of the foregoing, of the circumference of the fluid collection member 101. The opening 106 can exhibit a width that is greater than 50% of the circumference of the fluid collection member 101 since the vacuum (e.g., suction) through the conduit 108 pulls the fluid into the conduit 108. In some embodiments, the opening 106 may be vertically oriented (e.g., having a major axis parallel to the longitudinal axis of the device 100). In some embodiments, (not shown), the opening 106 may be horizontally oriented (e.g., having a major axis perpendicular to the longitudinal axis of the device 100). In an example, one or more portions of the fluid impermeable barrier 102 can be configured to be attached to the individual, such as adhesively attached (e.g., with a hydrogel adhesive) to the individual. According to an embodiment, a suitable adhesive for the impermeable barrier (or flanges) is a hydrogel layer, such as those disclosed in U.S. Patent Application Publication No. 2017/0189225, the disclosure of which is incorporated herein by reference in its entirety.


The fluid collection member 101 includes the wicking material 115 disposed in the chamber 104. The wicking material 115 may include one or more of the fluid permeable membrane 118 and the fluid permeable support 120, each disposed in the chamber 104. The fluid permeable membrane 118 can cover at least a portion (e.g., all) of the opening 106. The fluid permeable membrane 118 can be configured to wick any fluid away from the opening 106 thereby preventing the fluid from escaping the chamber 104. The fluid permeable membrane 118 can also wick the fluid generally towards an interior of the chamber 104, as discussed in more detail below. The fluid permeable membrane 118 can include any material that can wick the fluid. For example, the fluid permeable membrane 118 can include fabric, such as a gauze (e.g., a silk, linen, polymer based materials such as polyester, or cotton gauze), another soft fabric, or another smooth fabric. Forming the fluid permeable membrane 118 from gauze, soft fabric, and/or smooth fabric can reduce chafing caused by the fluid collection member 101.


The fluid permeable support 120 may be disposed in the chamber 104, such as concentrically within the fluid permeable membrane 118. The fluid permeable support 120 may be formed from material that is more rigid (e.g., less deformable) than the fluid permeable membrane 118, such as any of the materials disposed herein for a fluid permeable membrane. For example, the fluid permeable support 120 can include a porous nylon structure. The fluid permeable support 120 is configured to support the fluid permeable membrane 118 since the fluid permeable membrane 118 can be formed from a foldable, flimsy, or otherwise easily deformable material. For example, the fluid permeable support 120 can be positioned such that the fluid permeable membrane 118 is disposed between the fluid permeable support 120 and the fluid impermeable barrier 102. As such, the fluid permeable support 120 can support and maintain the position of the fluid permeable membrane 118. In an embodiment, the fluid permeable support 120 can be omitted from the fluid collection member 101.


In an embodiment, the fluid permeable membrane 118 and the fluid permeable support 120 can at least substantially completely fill the portions of the chamber 104 that are not occupied by the conduit 108. In another example, the fluid permeable membrane 118 and the fluid permeable support 120 may not substantially completely fill the portions of the chamber 104 that are not occupied by the conduit 108. In such an example, the fluid collection device 100 includes the reservoir 122 disposed in the chamber 104. The reservoir 122 is a substantially unoccupied portion of the chamber 104. The fluid(s) that is in the chamber 104 can flow through the fluid permeable membrane 118 and/or fluid permeable support 120 to the reservoir 122. The reservoir 122 can store at least some of the fluid(s) therein.


The fluid impermeable barrier 102 can store fluid(s) in the reservoir 122. The reservoir 122 may be disposed in any portion of the interior region of the chamber 104. For example, the fluid reservoir 122 may be positioned in the second end region of the chamber 104.


In an example, the reservoir 122 can be located at the portion of the chamber 104 that is closest to the inlet 110 (e.g., the second end region). However, the reservoir 122 can be located at different locations in the chamber 104. For example, the reservoir 122 can be located at the end of the chamber 104 that is closest to the outlet 112. In another example, fluid collection device 100 can include multiple reservoirs, such as a first reservoir that is located at the portion of the chamber of the chamber 104 that is closest to the inlet 110 (e.g., second end region) and a second reservoir that is located at the portion of the of the chamber 104 that is closest to the outlet 112 (e.g., first end region). In another example, the fluid permeable support 120 is spaced from at least a portion of the conduit 108 and the reservoir 122 can be the space between the fluid permeable support 120 and the conduit 108.


Other examples of fluid impermeable barriers, fluid permeable membranes, fluid permeable supports, chambers, and their shapes and configurations are disclosed in U.S. patent application Ser. No. 15/611,587 filed on Jun. 1, 2017 and U.S. patent application Ser. No. 15/260,103 filed on Sep. 8, 2016 (published as US 2016-0374848 on Dec. 29, 2016), the disclosure of each of which is incorporated herein, in its entirety, by this reference.


The fluid impermeable barrier 102, the fluid permeable membrane 118 and the fluid permeable support 120 can be configured to have the conduit 108 at least partially disposed in the chamber 104. For example, at least one of the fluid permeable membrane 118 and the fluid permeable support 120 can be configured to form a space that accommodates the conduit 108. In another example, the fluid impermeable barrier 102 can define an aperture 124 sized to receive the conduit 108 (e.g., at least one tube). The at least one conduit 108 can be disposed in the chamber 104 via the aperture 124 in the first end region of the device 100. The aperture 124 can be configured to form an at least substantially fluid tight seal against the conduit 108 or the at least one tube thereby substantially preventing the fluid(s) from escaping the chamber 104. In some embodiments, the aperture 124 may be disposed on the second end region nearer the reservoir 122. In such embodiments, the conduit 108 may be disposed in only the second end region with the inlet 110 being disposed in the second end region (e.g., the reservoir 122).


As previously discussed, the conduit 108 is configured to be coupled to, and at least partially extend between, one or more of the fluid storage container (not shown) and the vacuum source (not shown). In an example, the conduit 108 is configured to be directly connected to the vacuum source (not shown). In such an example, the conduit 108 can extend from the fluid impermeable barrier 102 by at least one foot, at least two feet, at least three feet, or at least six feet. In another example, the conduit 108 is configured to be indirectly connected to at least one of the fluid storage container (not shown) and the vacuum source (not shown). In some embodiments, the conduit is secured to a wearer's skin with a catheter securement device, such as a STATLOCK® catheter securement device available from C. R. Bard, Inc., including but not limited to those disclosed in U.S. Pat. Nos. 6,117,163; 6,123,398; and 8,211,063, the disclosures of which are all incorporated herein by reference in their entirety.


The inlet 110 and the outlet 112 are sized, positioned, or otherwise configured to place (e.g., directly or indirectly) the vacuum source (not shown) in fluid communication with the chamber 104 (e.g., the reservoir 122). In an example, the inlet 110 and/or the outlet 112 can form a male connector. In another example, the inlet 110 and/or the outlet 112 can form a female connector. In an example, the inlet 110 and/or the outlet 112 can include ribs that are configured to facilitate secure couplings. In an example, the inlet 110 and/or the outlet 112 can form a tapered shape. In an example, the inlet 110 and/or the outlet 112 can include a rigid or flexible material.


Locating the inlet 110 at or near a gravimetrically low point of the chamber 104 enables the conduit to receive more of the fluid(s) than if inlet 110 was located elsewhere and reduce the likelihood of pooling (e.g., pooling of the fluid(s) can cause microbe growth and foul odors). For instance, the fluid(s) in the fluid permeable membrane 118 and the fluid permeable support 120 can flow in any direction due to capillary forces. However, the fluid(s) may exhibit a preference to flow in the direction of gravity, especially when at least a portion of the fluid permeable membrane 118 and/or the fluid permeable support 120 is saturated with the fluid(s).


As the vacuum source (FIG. 1) applies a vacuum/suction in the conduit 108, the fluid(s) in the chamber 104 (e.g., at the second end region such as in the reservoir 122) may be drawn into the inlet 110 and out of the fluid collection member 101 of the fluid collection device 100 via the conduit 108.


In an example, the conduit 108 is configured to be at least insertable into the chamber 104. In such an example, the conduit 108 can include one or more markers (not shown) on an exterior thereof that are configure to facilitate insertion of the conduit 108 into the chamber 104. For example, the conduit 108 can include one or more markings thereon that are configured to prevent over or under insertion of the conduit 108, such as when the conduit 108 defines an inlet 110 configured to be disposed in or adjacent to the reservoir 122. In another example, the conduit 108 can include one or more markings thereon that are configured to facilitate correct rotation of the conduit 108 relative to the chamber 104. In an example, the one or more markings can include a line, a dot, a sticker, or any other suitable marking. In some examples, the conduit may be frosted or opaque (e.g., black) to obscure visibility of the fluid(s) therein.


In an example, one or more components of the fluid collection device 100 can include an antimicrobial material, such as an antibacterial material where the fluid collection device may contact the wearer or the bodily fluid of the wearer. The antimicrobial material can include an antimicrobial coating, such as a nitrofurazone or silver coating. The antimicrobial material can inhibit microbial growth, such as microbial growth due to pooling or stagnation of the fluid(s). In an example, one or more components (e.g., impermeable barrier 102, conduit 108, etc.) of the fluid collection device 100 can include an odor blocking or absorbing material such as a cyclodextrine containing material or a thermoplastic elastomer (TPE) polymer.


The at least one flange 140 can be disposed on a lower portion of the fluid collection member 101 (e.g., substantially opposite the opening 106). For example, the at least one flange 140 may extend from the fluid collection member 101 may have the at least one flange 140 affixed to or integrally formed in the fluid impermeable barrier 102.



FIG. 4 is a schematic cross-sectional view of the fluid collection device 400 taken along the plane A-A of FIG. 2A, according to an embodiment. The fluid collection device 400 may include the portable vacuum source 330 disposed therein. Except as otherwise disclosed herein, the fluid collection device 400 can be the same as or substantially similar to the fluid collection device 100 of FIG. 2A, in one or more aspects. The fluid collection device 400 can include fluid collection member 401 and the at least one flange 140. The fluid collection member 401 may be similar or identical to the fluid collection member 101 in one or more aspects, such as including one or more of the fluid impermeable barrier 102 that defines the chamber 104 and the opening 106, the wicking material 115, the fluid permeable membrane 118, the fluid permeable support 120, and the reservoir 122, or the conduit 108. The fluid collection device 400 includes the portable vacuum source 330 disposed therein. The portable vacuum source 330 may be similar or identical to the vacuum source 16 as disclosed herein, in one or more aspects. The portable vacuum source 330 may be sized to fit on or within the fluid collection device. The portable vacuum source may be sized and shaped for a person to carry. As shown, the portable vacuum source 330 may be at least partially disposed within the fluid impermeable barrier 102. While a portable vacuum source 330 is depicted in FIG. 4, a fixed vacuum source (e.g., vacuum line) may alternatively or additional be used with the fluid collection device 400.


The fluid collection device 400 includes the conduit 108 that is at least partially disposed in the chamber 104. For example, the wicking material 115 (e.g., the fluid permeable membrane 118, the fluid permeable support 120) may fill a portion of the chamber 104 and leave a portion vacant thereby forming the reservoir 122 between the wicking material 115 and the fluid impermeable barrier 102. The conduit 108 can include one or more walls that define an inlet 110 and the outlet 112. The inlet 110 enables at least some of the fluid(s) that is present in the chamber 104 to enter the conduit 108. In an example, the conduit 108 can be configured to have the inlet 110 located at, near, or spaced at a gravimetrically low point of the chamber 104. In an example, the conduit 108 can be configured to have the at least one inlet 110 disposed in or adjacent to the reservoir 122. As shown the conduit 108 can extend through at least a portion of the chamber 104, such as longitudinally through at least a portion of the wicking material 115 in a concentrically central region fluid collection member 115.


The conduit 108 can be in fluid communication with the interior region (e.g., reservoir 122) of the chamber 104 via the fluid impermeable barrier 102. As such, the fluid impermeable barrier 102 can define the aperture 124. In an example, as illustrated, the aperture 124 enables the conduit 108 to extend outwardly from the chamber 104 when the conduit 108 is only partially disposed in the chamber 104. In examples, the conduit 108 may include a plurality of separate sections. For example and as shown, the conduit 108 may include a first section A and section B. The first section A may include the inlet 110 extending from the distal end (e.g., first end region) to the portable vacuum source 330 and the B section may extend from the portable vacuum source 330 out of the aperture 124, such as to a fluid storage container (not shown).


The portable vacuum source 330 may include any of the portable vacuum pumps disclosed herein. For example, the portable vacuum source 330 may include a manual vacuum pump, a diaphragm pump, a centrifugal pump, a displacement pump, a magnetically driven pump, a peristaltic pump, or any pump configured to produce a vacuum. The portable vacuum source 330 may be sized to fit in the chamber 104 inside of the fluid impermeable barrier 102. In examples, the portable vacuum source 330 may sealed in a fluid tight housing or container. The portable vacuum source 330 may apply a vacuum (e.g., suction) in the A section of the conduit 108 effective to suction fluid from the chamber 104. The fluid may travel through the A section to the B section (e.g., through the portable vacuum source 330) and out of the fluid collection device 300 via the B section by flow induced by the vacuum or suction applied by the portable vacuum source 330. For example, the portable vacuum source 330 may include a centrifugal pump and an impeller therein may draw the fluid from the chamber 104 via the inlet 110 and force the fluid out of the chamber 104 via the B section of the conduit 108. Each of the A section and the B section of the conduit 108 may be in fluid communication with (e.g., sealed) the portable vacuum source 330. In some examples, the portable vacuum source 330 and the conduit 108 can be integrally formed together (e.g., exhibit single piece construction).



FIG. 5 is a schematic cross-sectional view of the fluid collection device 500 taken along the plane A-A of FIG. 2A, according to an embodiment. The fluid collection device 500 may include the portable vacuum source 330 disposed thereon. Except as otherwise disclosed herein, the fluid collection device 500 can be the same as or substantially similar to the fluid collection device 100 of FIG. 2A, in one or more aspects. The fluid collection device 500 can include fluid collection member 501 and the at least one flange 140. The fluid collection member 501 may be similar or identical to the fluid collection member 101 in one or more aspects, such as including one or more of the fluid impermeable barrier 102 that defines the chamber 104 and the opening 106, the wicking material 115, the fluid permeable membrane 118, the fluid permeable support 120, and the reservoir 122, or the conduit 108. The fluid collection member 501 of the fluid collection device 500 includes the portable vacuum source 330 disposed thereon. The portable vacuum source 330 may be attached to the fluid collection device 500 at or on the fluid impermeable barrier 102. While a portable vacuum source 330 is depicted in FIG. 5, a fixed vacuum source (e.g., vacuum line) may alternatively or additional be used with the fluid collection device 500.


The fluid collection device 500 includes the conduit 108 that is at least partially disposed within the fluid collection member 501. For example, the wicking material 115 (e.g., the fluid permeable membrane 118, the fluid permeable support 120) may fill a portion of the chamber 104 and leave a portion vacant thereby forming the reservoir 122 between the wicking material 115 and the fluid impermeable barrier 102. As shown the conduit 108 can extend through at least a portion of the chamber 104, such as longitudinally through at least a portion of the wicking material 115 in a concentrically central region fluid collection member 115 to the reservoir 122. The conduit 108 may extend through the wicking material 115 to the reservoir 122. The conduit 108 can include one or more walls that define an inlet 110 and the outlet 112. The inlet 110 enables at least some of the fluid(s) that is present in the chamber 104 to enter the conduit 108. In an example, the conduit 108 can be configured to have the inlet 110 located at, near, or spaced at a gravimetrically low point of the chamber 104. In an example, the conduit 108 can be configured to have the at least one inlet 110 disposed in or adjacent to the reservoir 122.


The conduit 108 can be in fluid communication with the interior region of the chamber 104 via the fluid impermeable barrier 102. As such, the fluid impermeable barrier 102 can define the aperture 124. In an example, as illustrated, the aperture 124 enables the conduit 108 to extend outwardly from the chamber 104 when the conduit 108 is only partially disposed in the chamber 104. In examples, the conduit 108 may include a plurality of separate sections. For example and as shown, the conduit 108 may include the first section A and the second section B. The first section A may include the inlet 110 extending from the distal end (e.g., first end region), out of the aperture 124, to the portable vacuum source 330 mounted thereto. The portable vacuum source 330 may be mounted to the outer surface of the fluid collection device 400. The B section may be attached to and extend from the portable vacuum source 330, such as to a fluid storage container (not shown).


The portable vacuum source 330 may include any of the portable vacuum pumps disclosed herein such as a manual vacuum pump, a diaphragm pump, a centrifugal pump, a displacement pump, a magnetically driven pump, a peristaltic pump, or any pump configured to produce a vacuum. The portable vacuum source 330 may be sized to fit in the chamber 104 inside of the fluid impermeable barrier 102. In examples, the portable vacuum source 330 may sealed in a fluid tight housing or container. The portable vacuum source 330 may apply a vacuum (e.g., suction) in the A section of the conduit 108 effective to suction fluid from the chamber 104. The fluid may travel through the A section out of the fluid collection device 400 to the portable vacuum source 330. The fluid may be removed from the portable vacuum source 330 via the B section by flow induced by the vacuum or suction applied by the portable vacuum source 330. For example, the portable vacuum source 330 may include a centrifugal pump and an impeller therein may draw the fluid from the chamber 104 via the inlet 110 and suction the fluid out of the chamber 104 via the portable vacuum source 330 to the B section of the conduit 108. Each of the A section and the B section of the conduit 108 may be in fluid communication with (e.g., sealed) the portable vacuum source 330. In some examples, the portable vacuum source 330 and the conduit 108 (e.g., one or both of the A section or the B section) can be integrally formed together to exhibit single piece construction.


The fluid collection devices shown in FIGS. 2-5 are examples of female fluid collection devices that are configured to collect fluid(s) from females (e.g., collect urine from a female urethra). However, the devices, systems, and methods disclosed herein can include male fluid collection devices shaped, sized, and otherwise configured to collect fluid(s) from males (e.g., a cup shaped fluid collection member to collect urine from a male urethra). In such examples, the flanges of the male fluid collection device may be located on the male fluid collection device to position and maintain the fluid collection device over the male urethra (e.g., penis). In any of the embodiments disclosed herein the conduits 108 may include or be operably coupled to a flow meter (not shown) to measure the flow of fluid(s) therein, one or more securement devices (e.g., a STATLOCK® securement device, not shown) or fittings to secure the conduit 108 to one or more components of the systems or devices disclosed herein (e.g., vacuum source or fluid storage container), or one or more valves to control the flow of fluid(s) in the systems and devices herein.


In an example, at least one of portion of the conduit 108 of the fluid collection devices or systems herein can be formed of an at least partially opaque material which can obscure the fluid(s) that is present therein. For example, the B section of the conduits 108 disclosed herein may be formed of an opaque material or translucent material while the A section may be formed of a transparent material or translucent material. In examples, the B section may include transparent or translucent material. Unlike the opaque or nearly opaque material, the translucent material allows a user of the devices and systems herein to visually identify fluid(s) or issues that are inhibiting the flow of fluid(s) within the conduit 108.


In any of the example, systems or devices disclosed herein, the system of fluid collection device may include moisture sensors (not shown) disposed inside of the chamber of the fluid collection device. In such examples, the moisture sensor may be operably coupled to a controller or directly to the vacuum source, and may provide electrical signals indicating that moisture is or is not detected in one or more portions of the chamber. The moisture sensor(s) may provide an indication that moisture is present, and responsive thereto, the controller of the vacuum source (e.g., vacuum device with a programmable controller) may direct the initiation of suction to the chamber to remove the fluid therefrom. Suitable moisture sensors may include capacitance sensors, volumetric sensors, potential sensors, resistance sensors, frequency domain reflectometry sensors, time domain reflectometry sensors, or any other suitable moisture sensor. In practice, the moisture sensors may detect moisture in the chamber and may provide a signal to the controller of the vacuum source to activate the vacuum source.


As noted above, the at least one flange 140 (e.g., pair of flanges) may be positioned on the fluid collection member in any of a number of positions and may extend therefrom at any angle. The cross-sectional shape of the fluid collection members disclosed herein may include any of various shapes or sizes. For example, the cross-sectional shape (along the plane B-B of FIG. 2A) may be substantially round (e.g., circular), elliptical, rectangular, triangular, irregular (e.g., having no specific shape), etc. FIGS. 6-8 are schematic cross-sectional views of female fluid collection devices taken along the plane B-B of FIG. 2, according to different embodiments.



FIG. 6 is a schematic cross-sectional view of the fluid collection device 100 taken along the plane B-B of FIG. 2A, according to an embodiment. The fluid collection device 100 includes the fluid collection member 101 and the at least one flange 140 extending therefrom. As shown, the fluid collection member 101 includes the fluid impermeable barrier 102, the wicking member 115 (e.g., the fluid permeable membrane 118 and the fluid permeable support 120), and the conduit 108, all concentrically arranged. As shown, the cross-sectional shape of the fluid collection member 101, and one or more components therein, may be generally round (e.g., circular or ellipsoid).


The at least one flange 140 may extend substantially tangentially from the fluid collection member 101 (e.g., the fluid impermeable barrier 102). For example, the at least one flange 140 may include at least 2 flanges 140, each extending from the fluid collection member 101 tangentially in substantially opposite directions from one another. “Substantially tangentially” may include flanges 140 that extend outwardly at an angle within 10% of 0° from an attachment point of the flange(s) on the outer surface of the fluid impermeable barrier. In examples, the at least one flange 140 may attach to the fluid collection member 101 at a point substantially opposite the opening 106. The fluid collection member 101 may extend toward the user past the flanges 140. Such arrangements may allow the fluid collection member 101 to be positioned on the region of the female urethra, such as on or between the labia.


In examples, the flange bodies 142 may have the adhesive member 144 bound thereto on a surface thereof that generally faces the same direction as the opening 106. In some examples, the flanges 140 may alternatively or additionally include adhesive members 144 on the surface of the flange body 142 that face generally away from the opening 106. The adhesive members 144 may allow the flange body 142 to be attached (e.g., temporarily adhered) to one or more skin surfaces of the subject that are adjacent to the urethra of the user, such as the thighs or pubic region. The adhesive members 144 may secure and maintain the fluid collection device 100 in a position to collect fluid from the user, such as between the labia to collect urine from a female subject.



FIG. 7 is a schematic cross-sectional view of the fluid collection device 700 taken from a view along the plane B-B of FIG. 2A, according to an embodiment. The fluid collection device 100 includes the fluid collection member 101 and the at least one flange 140 extending therefrom. As shown, the fluid collection member 101 includes the fluid impermeable barrier 102, the wicking member 115 (e.g., the fluid permeable membrane 118 and the fluid permeable support 120), and the conduit 108, all concentrically arranged. As shown, the cross-sectional shape of the fluid collection member 101, and one or more components therein, may be generally round (e.g., circular or ellipsoid).


The at least one flange 140 may extend substantially perpendicularly away from the fluid collection member 101 (e.g., the fluid impermeable barrier 102). For example, the at least one flange 140 may include at least 2 flanges 140, each extending from the fluid collection member 101 perpendicularly (e.g., in a radial direction) from the fluid impermeable barrier 102 and in substantially opposite directions from one another. “Substantially perpendicularly” may include flanges 140 that extend outwardly at an angle within 10% of 90° with respect to an outer surface of the fluid impermeable barrier at attachment point of the flange(s) 140 thereon. For examples and as shown, the at least one flange 140 may attach to the fluid collection member 101 and radially extend therefrom in radially opposite directions. The fluid collection member 101 may extend toward the user past the flanges 140. Such arrangements may allow the fluid collection member 101 to be positioned on the region of the female urethra, such as on or between the labia.


In examples, the flange bodies 142 may have the adhesive member 144 bound thereto on a surface thereof that generally faces the same direction as the opening 106. In some examples, the flanges 140 may alternatively or additionally include adhesive members 144 on the surface of the flange body 142 that face generally away from the opening 106. The adhesive members 144 may allow the flange body 142 to be attached (e.g., temporarily adhered) to one or more skin surfaces of the subject that are adjacent to the urethra of the user, such as the thighs or pubic region. The adhesive members 144 may secure and maintain the fluid collection device 100 in a position to collect fluid from the user, such as between the labia to collect urine from a female subject.


The cross-sectional shape of the fluid collection member and the position(s) of the components therein may vary. FIG. 8 is a schematic cross-sectional view of the fluid collection device 800 taken from a view along the plane B-B of FIG. 2A, according to an embodiment. The fluid collection device 800 may be similar or identical to the fluid collection device 100, in one or more aspects. The fluid collection device 800 includes the fluid collection member 801 and the at least one flange 140 extending therefrom. The fluid collection member 801 may be similar or identical to the fluid collection member 101, in one or more aspects. For example, the fluid collection member 801 includes the fluid impermeable barrier 102, the wicking member 115 (e.g., the fluid permeable membrane 118 and the fluid permeable support 120), and the conduit 108. The cross-sectional shape of the fluid collection member 801 may be generally rectangular (e.g., with rounded corners) as shown, or elliptical. In such examples, the fluid collection member 801 may provide coverage (e.g., fluid absorption) of a larger surface area than the fluid collection member 101 (FIG. 6). In examples, the fluid impermeable barrier 102 may be shaped to provide a relatively wide cross-sectional shape. As shown, the fluid impermeable barrier 102 may form the chamber 104 having a gravimetrically low portion, such as in a V-notched or dished shape. The wicking material 115 may fill at least a portion of the chamber 104. For example, the fluid permeable support 120 may fill an interior portion of the chamber 104, and the fluid permeable member 118 may extend around at least a portion of the fluid permeable support 120. In examples, the fluid permeable support 120 may include region therein for accommodating the conduit 108. In examples, the conduit 108 may be disposed in the gravimetrically low point or region of the chamber 104. As shown, one or more of the conduit 108, fluid permeable member 118, or the fluid permeable support 120 may be non-concentrically disposed (e.g., not centered) in the fluid collection member 801 or fluid impermeable barrier 102.


Additional or alternative shapes for the fluid collection members are considered. For example, the fluid collection member may have a substantially triangular cross-sectional shape where a corner or apex of the triangle faces the user.


The at least one flange 140 may extend substantially perpendicularly away from the fluid collection member 801 (e.g., the fluid impermeable barrier 102). For example, the at least one flange 140 may include at least 2 flanges 140, each extending from the fluid collection member 801 perpendicularly from the fluid impermeable barrier 102 and in substantially opposite directions from one another. For examples and as shown, the at least one flange 140 may attach to the fluid collection member 801 in radially opposite directions. The fluid collection member 801 may extend toward the user past the flanges 140. Such arrangements may allow the fluid collection member 801 to be positioned on the region of the female urethra, such as on or between the labia.


In examples, the flange bodies 142 may have the adhesive member 144 bound thereto on a surface thereof that generally faces the same direction as the opening 106. In some examples, the flanges 140 may alternatively or additionally include adhesive members 144 on the surface of the flange body 142 that face generally away from the opening 106. The adhesive members 144 may allow the flange body 142 to be attached (e.g., temporarily adhered) to one or more skin surfaces of the subject that are adjacent to the urethra of the user, such as the thighs or pubic region. The adhesive members 144 may secure and maintain the fluid collection device 100 in a position to collect fluid from the user, such as between the labia to collect urine from a female subject.


In some examples, the fluid collection devices herein may include more than one conduit therein. the more than one conduit may be disposed in a plurality of regions therein. In examples, conduit 108 may include a plurality of inlets.


Fluid collection devices having flanges thereon may be configured for use with male users. Devices and methods described herein can be configured to collect urine from a male user, such as having a fluid collection device shaped and sized to receive a male urethra (e.g., penis) therein. FIGS. 9A and 9B are isometric and schematic cross-sectional views of a male fluid collection device 900, according to an embodiment.


Referring to FIGS. 9A and 9B, the fluid collection device 900 includes a receptacle 950 and a cup portion 952. The receptacle 950 is sized, shaped, and made of a material to be coupled to skin that surrounds the male urethra and have the male urethra positioned therethrough. For example, the receptacle 950 can include an annular base 954 that defines an opening 956 in the receptacle 950. The annular base 954 is sized and shaped to be positioned around the male urethra (e.g., positioned around and/or over the penis) and the opening 956 can be configured to have the male urethra positioned therethrough. The annular base 954 can also be sized, shaped, made of a material, or otherwise configured to be coupled (e.g., adhesively attached, such as with a hydrogel adhesive) to the skin around the male urethra (e.g., around the penis) with one or more flanges 940. In examples, the receptacle 950 may include one or more flanges that extend outwardly to contact the wearer of the fluid collection device 900. The annular base 954 may include, define, or be affixed to at least one flange 940 that extends substantially perpendicular to the lip 960.


The flange(s) 940 may be similar or identical to the flange 140 disclosed herein, in one or more aspects. For example, the flange 940 may include the flange body 942 and an adhesive 944 (or other attachment body for attaching the flange body 942 to a subject or clothes of the subject). The flange body 942 may be similar or identical to the flange body 142 disclosed herein, in one or more aspects. For example, the flange body 942 may be formed from a thermoplastic elastomer, polyethylene, polyvinyl chloride, ethylene vinyl acetate, polytetrafluoroethylene, latex, silicon, fabric, woven cloth, etc. The flange body 942 may extend substantially perpendicularly to the lip 960. The adhesive 944 may be similar or identical to the adhesive 144 disclosed herein, in one or more aspects. In some examples, the more than two flanges 940 may extend from the annular base 954. In some examples (not shown), the flange 940 may include a single flange body 942 that extends from and around substantially all of the annular base 954. In such examples, the adhesive 944 may be located at discrete points or around substantially all of the surface of the flange body 942 that is expected to contact the wearer. One or more portions of the receptacle 950 may be formed from the same material as the fluid impermeable barrier 102 such as a fluid impermeable polymer (e.g., silicone, polypropylene, polyethylene, polyethylene terephthalate, polyurethane, a polycarbonate, polyvinyl chloride, latex, silicone, etc.), a metal film, another suitable material, or combinations thereof.


In an example, the annular base 954 can exhibit the general shape of the skin surface that the annular base 954 is selected to be coupled with and/or can be flexible thereby allowing the annular base 954 to conform to any shape of the skin surface. The receptacle 950 also defines a hollowed region that is configured to receive (e.g., seal against) the cup portion 952. For example, the receptacle 950 can include the lip 960 that extends upwardly from the annular base 954. The lip 960 may be tall enough to prevent the cup portion 952 from being accidentally removed from the receptacle 950 (e.g., at least 0.5 cm tall, 1 cm tall, at least 2 cm tall, or at least 5 cm tall). In some examples, the annular base 954 is optional. For example, the receptacle 950 may only include the flange 954. In some examples (not shown), the fluid collection device may have a one piece design, with the cup portion 952 and the receptacle 950 being a single piece. In some examples, the receptacle 950 is optional.


The cup portion 952 includes (e.g., may be formed from) a fluid impermeable barrier 902 that is sized and shaped to fit into the hollowed region of the receptacle 950. The cup portion 952 may be shaped to retain a fluid therein. For example, the fluid impermeable barrier 902 may define the cup portion 952, such as a substantially tubular (e.g., cylindrical) body having an enclosed end as illustrated in FIGS. 9A and 9B. Accordingly, the cup portion 552 may have a generally cupped shape with a chamber 504 therein. The fluid impermeable barrier 902 may be similar or identical to the fluid impermeable barrier 102, in one or more aspects. The fluid impermeable barrier 902 partially defines the chamber 904. The fluid impermeable barrier 902 may also define an opening 956 extending through the fluid impermeable barrier 902 that is configured to have a male urethra positioned therethrough. The fluid impermeable barrier 902 may also include at least one passageway 962 (e.g., vacuum relief hole) that allows the chamber 904 to remain substantially at atmospheric pressure. The at least one passageway 962 may be located at any point on the cup portion 952, such as near or nearer the opening 956. The cup portion 952 also includes at least a portion of the conduit 108 therein, such as at least partially disposed in the chamber 904. For example, the conduit 108 may extend from the cup portion 952 to a region at least proximate to the opening 956. The region proximate to the opening 956 may be disposed near or on the skin around the male urethra (e.g., on the penis). Accordingly, when a patient lays on their back, fluid (e.g., urine) may aggregate near the opening 956 against the skin of the subject. The fluid may be removed from the chamber 904 via the conduit 108. In some examples, the cup portion 952 of the fluid impermeable barrier 902 may be constructed of a material and/or have a thickness that allows the cup portion 952 to collapse when placed under vacuum, such as to remove air around a penis in the fluid collection device 900 during use. In such examples, the conduit 108 may extend only into the chamber 904 at the aperture 924 (e.g., not through to the area adjacent the opening). In such examples, urine may be collected and removed from the fluid collection device 900 at the end nearest the aperture 924. In such examples, the at least one passageway may be located nearest the opening 956.


The fluid collection device 900 may include wicking material therein. The fluid collection device 900 may include the fluid permeable membrane 118. The fluid permeable membrane 118 may be disposed between the fluid impermeable barrier 902 of the cup portion 952 and a penis inserted into the chamber 904. The fluid collection device 900 may include a fluid permeable support 120. The fluid permeable support 120 may be positioned between the cup portion 952 and a penis inserted into the chamber 904, such as between the fluid permeable membrane 118 and the fluid impermeable barrier 902. The sidewalls or the end of the chamber 904 may be covered with one or both the fluid permeable membrane 118 or the fluid permeable support 120.


In some examples, a vacuum source (e.g., vacuum source 16 of FIG. 1) may be remotely located from the cup portion 952. In such examples, the conduit 108 may extend out of and away from the cup portion 952 to the vacuum source (e.g., portable vacuum source). The inlet 110 of the conduit 108 is in fluid communication with the vacuum source, either directly or indirectly. The outlet (not shown) may be in fluid communication with a fluid storage container (not shown) through the conduit 108 in the direction shown by the arrows. The fluid impermeable barrier 902 may include at least one aperture 924 that is sized and shaped to receive and seal against the conduit 108, such as within the chamber 904. Accordingly, the interior region of the chamber 904 may be in fluid communication with the vacuum source 16 via the conduit 108. As the vacuum source applies a vacuum/suction in the direction of the arrows in FIG. 9B, the fluid in the chamber 904 may be removed through the conduit 108. In some examples, the fluid may be pumped via the vacuum source 16 through one or more sections of conduit to the fluid storage container (not shown). In some examples, the vacuum source may be located on or in the cup portion 952 in a manner similar or identical to the vacuum source 330 located within or on the fluid impermeable barrier 102 in FIGS. 4 and 5, in one or more aspects.


In an example, portions of the chamber 904 may be substantially empty due to the varying sizes and rigidity of the male penis. However, in some examples, the outermost regions of the chamber 904 (e.g., periphery of the interior regions of the cup portion 952) can include a porous material (e.g., one or more of the fluid permeable membrane 118 and fluid permeable support 120) positioned (e.g., at the end of the cavity) and configured to blunt a stream of urine from the male urethra, thereby limiting splashing and/or to direct the fluid(s) to a selected region of the chamber 904. Since the chamber 904 is substantially empty (e.g., substantially all of the chamber 904 forms a reservoir), the fluids are likely to pool at a gravimetrically low point of the chamber 904. The gravimetrically low point of the chamber 904 can be at an intersection of the skin of an individual and the fluid collection device 900, a corner formed in the cup portion 952, or another suitable location depending on the orientation of the wearer. The inlet 110 of the conduit 108 can be positioned to be adjacent or proximate to the gravimetrically low point of the chamber 904, such as adjacent to the annular base 954. For example, the inlet 110 may be co-extensive with or offset from the opening 956. In examples, the inlet may be positioned adjacent to the terminal end of the cup portion 952 (e.g., substantially opposite the opening).


During operation, a male using the fluid collection device 900 can discharge fluid(s) (e.g., urine) into the chamber 904. The fluid(s) can pool or otherwise be collected in the chamber 904. At least some of the fluid(s) can enter the interior of the conduit 108 via the inlet 110. The fluid may be drawn out of the fluid collection device 900 via the vacuum/suction provided by the vacuum source. In some examples, during operation, the passageway 962 may substantially maintain the pressure in the chamber 904 at atmospheric pressure even though fluid is introduced into and subsequently removed from the chamber 904.



FIG. 10 is a flow diagram of a method 1000 to use any of the fluid collection devices, members, and/or fluid collection systems disclosed herein, according to an embodiment. The method 1000 can include act 1010, which recites “positioning an opening of a fluid collection device adjacent to a female urethra or around a male urethra of a user, the opening defined by a fluid impermeable barrier of the fluid collection device.” Act 1010 may be followed by act 1020, which recites “securing the fluid collection device to the user.” Act 1020 may be followed by act 1030, which recites “receiving fluid from the female urethra or male urethra into a chamber of the fluid collection device, the chamber of the fluid collection device at least partially defined by the fluid impermeable barrier.”


Acts 1010, 1020, 1030 of the method 1000 are for illustrative purposes. For example, the act 1010, 1020, 1030 of the method 1000 can be performed in different orders, split into multiple acts, modified, supplemented, or combined. In an example, one or more of the acts 1010, 1020, 1030 of the method 1000 can be omitted from the method 1000. Any of the acts 1010, 1020, or 1030 can include using any of the fluid collection devices or systems disclosed herein.


Act 1010 recites “positioning an opening of a fluid collection device adjacent to a female urethra or around a male urethra of a user, the opening defined by a fluid impermeable barrier of the fluid collection device.” In some examples, act 1010 can include positioning the opening of a female fluid collection device such that the fluid permeable membrane of the female fluid collection device abuts or is positioned proximate to the female urethra. For example, positioning an opening of a fluid collection device adjacent to a female urethra of a user may include positioning opening of the fluid collection member of the fluid collection device on, adjacent to, between the labia. In examples the female fluid collection device may be similar or identical to the fluid collection device 100, 400, 500, 700, or 800 (FIGS. 2A-8), in one or more aspects.


In some examples, act 1010 can include positioning the opening of a male fluid collection device around a urethra of a male user such that the urethra of the user is positioned within the fluid collection device. For example, positioning an opening of a fluid collection device around a male urethra of a user may include positioning the penis of a user in the cup portion of the male fluid collection device. In examples the male fluid collection device may be similar or identical to the fluid collection device 900 (FIG. 9), in one or more aspects. In such examples, the method 1000 can include positioning a cup portion of the male fluid collection device in a hollowed region of the receptacle such that the male urethra is positioned in the cup portion through the opening in the receptacle of the male fluid collection device. The flanges on the receptacle may be used to secure the fluid collection device to a male user.


Act 1020 recites, “securing the fluid collection device to the user.” Securing the fluid collection device to the user may include affixing one or more flanges of the fluid collection device to the user or clothing of the user. In examples, securing the fluid collection device to the user can include adhering the adhesion member of the at least one flange of the fluid collection device to the user. In examples, securing the fluid collection device to the user can include adhering the adhesion member(s) of the at least one flange (e.g., flanges) of the fluid collection device to one or more of the lower abdomen, inner thigh(s), testicles, pubic region, hip region, or perineum of the user (or on clothing over any of the aforementioned regions). For example, securing the fluid collection device to the user can include adhering the adhesion member(s) of the at least one flange of the fluid collection device to the inner thigh(s) of a female user. Securing the fluid collection device to the user can include adhering the adhesion member of the at least one flange of the fluid collection device to the garment (e.g., the underwear) of the user. For example, adhering the adhesion member of the at least one flange of the fluid collection device to the garment may include adhering one or more flanges on or around the crotch (e.g., gusset) of underwear of the user. Securing the fluid collection device to the user may include securing the fluid collection device to the user to maintain the opening adjacent to, on, or over the urethra of the user, even when the user moves.


Act 1030 recites “receiving fluid from the female urethra or male urethra into a chamber of the fluid collection device, the chamber of the fluid collection device at least partially defined by the fluid impermeable barrier.” In examples, act 1030 can include retaining the fluid within the chamber, such as in a gravimetrically low point therein. In some examples, act 1030 can include wicking the fluid away from the opening using wicking material (e.g., fluid permeable membrane and a fluid permeable support). In some examples, act 1030 can include receiving the fluid into the chamber of the fluid collection device. In either example, act 1030 can include flowing the fluid towards a portion of the chamber that is in fluid communication with an inlet of a conduit in fluid communication with a vacuum source. For instance, act 1030 can include flowing the fluid to a substantially unoccupied portion of the chamber (e.g., a reservoir), to a gravimetrically low point of the chamber, etc. The fluid can include one or more fluids, such as urine, liquid blood, sweat, etc. In some examples, receiving fluid from the female urethra into a chamber of the fluid collection device, the chamber of the fluid collection device at least partially defined by the fluid impermeable barrier may include wicking the fluid into the chamber via the fluid permeable membrane and fluid permeable support of the fluid collection device. For example, wicking the fluid into the chamber via the fluid permeable membrane and fluid permeable support may include wicking urine into the reservoir in the fluid collection device.


The method 1000 may include removing at least some of the fluid from the fluid collection device. For example, removing at least some of the fluid from the fluid collection device may include removing the fluid from within the chamber of the fluid collection device. Such removal may include applying suction with a vacuum source effective to suction the fluid from the chamber via a conduit disposed therein (which conduit may be in fluid communication with the vacuum source). In examples, removing fluids from the fluid collection device by applying suction with a vacuum source effective to suction (e.g., vacuum) the fluid from the chamber via a conduit disposed therein include using any of the vacuum sources disclosed herein, such as a portable vacuum source. In an example, applying suction can include activating the vacuum source (e.g., portable suction device) in fluid communication with the inlet of the conduit in the fluid collection device. In examples, activating the vacuum source in fluid communication with the inlet of the conduit in the fluid collection device can include supplying power to the vacuum source by one or more of flipping an on/off switch, pressing a button, opening a valve, connecting the fluid collection device into a vacuum line, plugging a portable vacuum source into a power outlet, putting batteries into the portable vacuum source, etc. In examples, the vacuum source may include a hand operated vacuum pump and applying suction with a vacuum source may include manually operating the hand operated vacuum pump effective to suction the fluid from the chamber via the conduit disposed therein that is in fluid communication with the (portable) vacuum source. In examples, the vacuum source may include a plumbed vacuum line and applying suction with a vacuum source may include manually connecting to the plumbed vacuum line to the fluid collection device (e.g., the conduit) or opening a valve therebetween effective to suction the fluid from the chamber via the conduit disposed therein.


In examples, applying suction with a vacuum source effective to suction the fluid from the chamber via a conduit disposed therein and in fluid communication with the vacuum source can be effective to remove at least some fluid (e.g., urine) from the chamber (e.g., interior region) of the fluid collection device. In examples, applying suction with a vacuum source effective to suction the fluid from the chamber via a conduit disposed therein and in fluid communication with the vacuum source can be effective to transfer at least some of the fluid from the chamber of the fluid collection device to a fluid storage container (e.g., a bottle or bag). In some examples, applying suction with a vacuum source effective to suction the fluid(s) from the chamber may include removing fluid from one or more of a reservoir, fluid permeable support, or fluid permeable membrane of the fluid collection device.


In examples, the vacuum source (e.g., suction device) may disposed on or within the fluid collection device and applying suction with the vacuum source may include activating the vacuum source. In examples, the vacuum source may be spaced from the fluid collection device and applying suction with the vacuum source may include activating the vacuum source, such as a portable vacuum source.


In examples, applying suction with a vacuum source effective to suction the fluid from the chamber via a conduit disposed therein and in fluid communication with the vacuum source may include detecting moisture in the chamber (e.g., via one or more moisture sensors) and responsive thereto, activating the vacuum source to provide suction in the chamber. The control of the vacuum source responsive to the signals indicating that moisture or a level thereof is present in the chamber can be automatic, such as via a controller, or may merely provide an indication that a level of moisture is present that may necessitate removal of fluid from the chamber of the fluid collection device. In the latter case, a user may receive the indication and activate the vacuum source such as a pump.


In an example, the method 1000 can include collecting the fluid that is removed from the fluid collection device, such as into a fluid storage container that is spaced from the fluid collection device and in fluid communication with the conduit. The fluid storage container can include any of the fluid storage containers disclosed herein.


While various aspects and embodiments have been disclosed herein, other aspects and embodiments are contemplated. The various aspects and embodiment disclosed herein are for purposes of illustration and are not intended to be limiting.

Claims
  • 1. A fluid collection device, comprising: a fluid collection member, including: a fluid impermeable barrier at least partially defining a chamber, the fluid impermeable barrier also defining an opening extending therethrough, the opening configured to be positioned adjacent to a female urethra or have a male urethra positioned therethrough;wicking material disposed at least partially within the chamber; anda conduit disposed within the chamber, the conduit including an inlet positioned within the fluid collection device and an outlet configured to be fluidly coupled to a portable vacuum source; andat least one flange extending outwardly from the fluid collection member, the at least one flange including a flange body having an adhesive member thereon, wherein the flange body is attached to the fluid impermeable barrier.
  • 2. The fluid collection device of claim 1, wherein the at least one flange extends substantially tangentially from the fluid collection member.
  • 3. The fluid collection device of claim 1, wherein the at least one flange extends substantially perpendicularly from the fluid collection member.
  • 4. The fluid collection device of claim 1, wherein the fluid collection member is substantially cylindrical.
  • 5. The fluid collection device of claim 1, wherein the wicking material includes one or more of a fluid permeable membrane or a fluid permeable support.
  • 6. The fluid collection device of claim 5, wherein the fluid permeable membrane extends across the opening and the fluid permeable support is disposed beneath the fluid permeable membrane.
  • 7. The fluid collection device of claim 5, further comprising a reservoir defined between the fluid impermeable barrier and one or more of the fluid permeable membrane or the fluid permeable support, and wherein the inlet is positioned in or adjacent to the reservoir.
  • 8. The fluid collection device of claim 1, wherein the fluid impermeable barrier is shaped to form a cup portion that connects with a receptacle configured to be positioned against a user, and the at least one flange extends from the receptacle.
  • 9. A fluid collection system, comprising: a fluid storage container configured to hold a fluid;a fluid collection device in fluid communication with the fluid storage container, the fluid collection device including: a fluid collection member, including: a fluid impermeable barrier at least partially defining a chamber, the fluid impermeable barrier also defining an opening extending therethrough, the opening configured to be positioned adjacent to a female urethra or have a male urethra positioned therethrough;a wicking material disposed at least partially within the chamber; anda conduit disposed within wicking material, the conduit including an inlet positioned within the fluid collection device and an outlet configured to be in fluid communication with a vacuum source; andat least one flange extending outwardly from the fluid collection member, the at least one flange including a flange body and an adhesive member thereon, wherein the flange body is attached to the fluid impermeable barrier;a vacuum source in fluid communication with one or more of the fluid storage container or the fluid collection device, the vacuum source configured to draw fluid from the fluid collection device.
  • 10. The fluid collection system of claim 9, wherein the fluid collection member includes a generally cylindrical shape.
  • 11. The fluid collection system of claim 9, wherein the at least one flange extends substantially perpendicularly from the fluid impermeable barrier.
  • 12. The fluid collection system of claim 9, wherein the at least one flange extends substantially tangentially from the fluid impermeable barrier.
  • 13. The fluid collection system of claim 9, wherein the vacuum source includes a portable vacuum source disposed within the fluid collection device.
  • 14. The fluid collection system of claim 9, wherein: the fluid collection device is spaced from and positioned upstream from the fluid storage container; andthe vacuum source is positioned downstream from and outside of the fluid collection device.
  • 15. A method to collect fluid, the method comprising: positioning an opening of a fluid collection device adjacent to a female urethra or a male urethra of a user, the opening defined by a fluid impermeable barrier of the fluid collection device;securing the fluid collection device to the user with at least one flange attached to the fluid collection device; andreceiving fluid from the female urethra or male urethra into a chamber of the fluid collection device, the chamber of the fluid collection device at least partially defined by the fluid impermeable barrier.
  • 16. The method of claim 15, wherein securing the fluid collection device to the user includes affixing the at least one flange to the user or clothing of the user.
  • 17. The method of claim 15, wherein: the fluid collection device is configured as a female fluid collection device having: a fluid impermeable barrier defining a chamber therein;at least one flange extending from the fluid impermeable barrier, the at least one flange including a flange body and an adhesive member therein, wherein the flange body is attached to the fluid impermeable barrier; anda conduit extending into the chamber; andsecuring the fluid collection device to the user includes attaching the at least one flange to skin or clothing of the user.
  • 18. The method of claim 15, wherein: the fluid collection device is configured as a male fluid collection device having: a fluid impermeable barrier defining a cup portion; anda receptacle configured to be positioned against the user and hold the cup portion thereon, the receptacle including at least one flange extending therefrom, the at least one flange including a flange body and an adhesive member therein, wherein the flange body is attached to the fluid impermeable barrier; anda conduit extending into the chamber; andsecuring the fluid collection device to the user includes attaching the at least one flange to skin or clothing of the user.
  • 19. The method of claim 15, further comprising removing at least some of the fluid from the fluid collection device with a vacuum source effective to suction the fluid from the chamber via a conduit disposed therein and in fluid communication with the vacuum source.
  • 20. The method of claim 15, wherein the vacuum source is disposed within the fluid collection device and applying suction with the vacuum source includes activating the vacuum source.
  • 21. The method of claim 15, wherein the vacuum source is spaced from the fluid collection device and applying suction with the vacuum source includes activating the vacuum source.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is U.S. Nationalization of PCT International Application No. PCT/US2019/029610 filed on 29 Apr. 2019, which claims priority to U.S. Provisional Application No. 62/665,321 filed on 1 May 2018, the disclosure of each of which is incorporated herein in its entirety by this reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2019/029610 4/29/2019 WO
Publishing Document Publishing Date Country Kind
WO2019/212951 11/7/2019 WO A
US Referenced Citations (767)
Number Name Date Kind
1032841 Koenig Jul 1912 A
1178644 Johnson Apr 1916 A
1742080 Jones Dec 1929 A
1979899 Obrien et al. Nov 1934 A
2262772 Peder Nov 1941 A
2326881 Packer Aug 1943 A
2379346 Farrell Jun 1945 A
2613670 Edward Oct 1952 A
2616426 Adele Nov 1952 A
2644234 Earl Jul 1953 A
2859786 Tupper Nov 1958 A
2944551 Carl Jul 1960 A
2968046 Duke Jan 1961 A
2971512 Reinhardt Feb 1961 A
3032038 Swinn May 1962 A
3077883 Hill Feb 1963 A
3087938 Hans et al. Apr 1963 A
3194238 Breece Jul 1965 A
3198994 Hildebrandt et al. Aug 1965 A
3221742 Egon Dec 1965 A
3312981 Mcguire et al. Apr 1967 A
3349768 Keane Oct 1967 A
3362590 Gene Jan 1968 A
3366116 Huck Jan 1968 A
3398848 Donovan Aug 1968 A
3400717 Bruce et al. Sep 1968 A
3406688 Bruce Oct 1968 A
3424163 Gunnar Jan 1969 A
3425471 Yates Feb 1969 A
3511241 Lee May 1970 A
3512185 Ellis May 1970 A
3520300 Flower Jul 1970 A
3528423 Lee Sep 1970 A
3613123 Langstrom Oct 1971 A
3648700 Warner Mar 1972 A
3651810 Ormerod Mar 1972 A
3661155 Lindan May 1972 A
3699815 Holbrook Oct 1972 A
3726277 Hirschman Apr 1973 A
3742952 Magers et al. Jul 1973 A
3757355 Allen et al. Sep 1973 A
3788324 Lim Jan 1974 A
3843016 Bornhorst et al. Oct 1974 A
3863638 Rogers et al. Feb 1975 A
3863798 Kurihara et al. Feb 1975 A
3864759 Horiuchi Feb 1975 A
3881486 Fenton May 1975 A
3915189 Holbrook et al. Oct 1975 A
3998228 Poidomani Dec 1976 A
3999550 Martin Dec 1976 A
4015604 Csillag Apr 1977 A
4020843 Kanall May 1977 A
4022213 Stein May 1977 A
4027776 Douglas Jun 1977 A
4116197 Bermingham Sep 1978 A
4180178 Turner Dec 1979 A
4187953 Turner Feb 1980 A
4194508 Anderson Mar 1980 A
4200102 Duhamel Apr 1980 A
4202058 Anderson May 1980 A
4233025 Larson et al. Nov 1980 A
4233978 Hickey Nov 1980 A
4246901 Frosch et al. Jan 1981 A
4257418 Hessner Mar 1981 A
4270539 Frosch et al. Jun 1981 A
4281655 Terauchi Aug 1981 A
4292916 Bradley et al. Oct 1981 A
4352356 Tong Oct 1982 A
4360933 Kimura et al. Nov 1982 A
4365363 Windauer Dec 1982 A
4387726 Denard Jun 1983 A
4425130 Desmarais Jan 1984 A
4446986 Bowen et al. May 1984 A
4453938 Brendling Jun 1984 A
4457314 Knowles Jul 1984 A
4476879 Jackson Oct 1984 A
4526688 Schmidt, Jr. et al. Jul 1985 A
4528703 Kraus Jul 1985 A
D280438 Wendt Sep 1985 S
4551141 Mcneil Nov 1985 A
4553968 Komis Nov 1985 A
4581026 Schneider Apr 1986 A
4610675 Triunfol Sep 1986 A
4620333 Ritter Nov 1986 A
4626250 Schneider Dec 1986 A
4627846 Ternstroem Dec 1986 A
4631061 Martin Dec 1986 A
4650477 Johnson Mar 1987 A
4656675 Fajnsztajn Apr 1987 A
4681570 Dalton Jul 1987 A
4692160 Nussbaumer Sep 1987 A
4707864 Ikematsu et al. Nov 1987 A
4713066 Komis Dec 1987 A
4747166 Kuntz May 1988 A
4752944 Conrads et al. Jun 1988 A
4769215 Ehrenkranz Sep 1988 A
4772280 Rooyakkers Sep 1988 A
4790830 Hamacher Dec 1988 A
4790835 Elias Dec 1988 A
4791686 Taniguchi et al. Dec 1988 A
4795449 Schneider Jan 1989 A
4798603 Meyer et al. Jan 1989 A
4799928 Crowley Jan 1989 A
4804377 Hanifl et al. Feb 1989 A
4812053 Bhattacharjee Mar 1989 A
4820297 Kaufman et al. Apr 1989 A
4846818 Keldahl et al. Jul 1989 A
4846909 Klug et al. Jul 1989 A
4865595 Heyden Sep 1989 A
4880417 Yabrov et al. Nov 1989 A
4882794 Stewart, III Nov 1989 A
4883465 Brennan Nov 1989 A
4886508 Washington Dec 1989 A
4886509 Mattsson Dec 1989 A
4889532 Metz et al. Dec 1989 A
4889533 Beecher Dec 1989 A
4903254 Haas Feb 1990 A
4905692 More Mar 1990 A
4936838 Cross et al. Jun 1990 A
4955922 Terauchi Sep 1990 A
4957487 Gerow Sep 1990 A
4965460 Tanaka et al. Oct 1990 A
4987849 Sherman Jan 1991 A
5002541 Conkling et al. Mar 1991 A
5004463 Nigay Apr 1991 A
5031248 Kemper Jul 1991 A
5045077 Blake Sep 1991 A
5045283 Patel Sep 1991 A
5049144 Payton Sep 1991 A
5053339 Patel Oct 1991 A
5058088 Haas et al. Oct 1991 A
5071347 Mcguire Dec 1991 A
5078707 Peter Jan 1992 A
5084037 Barnett Jan 1992 A
5100396 Zamierowski Mar 1992 A
5147301 Ruvio Sep 1992 A
5195997 Carns Mar 1993 A
5203699 Mcguire Apr 1993 A
5244458 Takasu Sep 1993 A
5246454 Peterson Sep 1993 A
5267988 Farkas Dec 1993 A
5275307 Freese Jan 1994 A
5294983 Ersoz et al. Mar 1994 A
5295983 Kubo Mar 1994 A
5300052 Kubo Apr 1994 A
5312383 Kubalak May 1994 A
5318550 Cermak et al. Jun 1994 A
5340840 Park et al. Aug 1994 A
5382244 Telang Jan 1995 A
5423784 Metz Jun 1995 A
5466229 Elson et al. Nov 1995 A
5478334 Bernstein Dec 1995 A
5499977 Marx Mar 1996 A
5543042 Filan et al. Aug 1996 A
D373928 Green Sep 1996 S
5605161 Cross Feb 1997 A
5618277 Goulter Apr 1997 A
5628735 Skow May 1997 A
5636643 Argenta et al. Jun 1997 A
5637104 Ball et al. Jun 1997 A
5674212 Osborn, III et al. Oct 1997 A
5678564 Lawrence et al. Oct 1997 A
5678654 Uzawa Oct 1997 A
5687429 Rahlff Nov 1997 A
5695485 Duperret et al. Dec 1997 A
5752944 Dann et al. May 1998 A
5772644 Bark et al. Jun 1998 A
5792132 Garcia Aug 1998 A
5827243 Palestrant Oct 1998 A
5827247 Kay Oct 1998 A
5827250 Fujioka et al. Oct 1998 A
5827257 Fujioka et al. Oct 1998 A
D401699 Herchenbach et al. Nov 1998 S
5865378 Hollinshead et al. Feb 1999 A
5887291 Bellizzi Mar 1999 A
5894608 Birbara Apr 1999 A
D409303 Oepping May 1999 S
5911222 Lawrence et al. Jun 1999 A
5957904 Holland Sep 1999 A
5968026 Osborn, III Oct 1999 A
5972505 Phillips et al. Oct 1999 A
6050983 Moore et al. Apr 2000 A
6059762 Boyer et al. May 2000 A
6063064 Tuckey et al. May 2000 A
6098625 Winkler Aug 2000 A
6105174 Karlsten et al. Aug 2000 A
6113582 Dwork Sep 2000 A
6117163 Bierman Sep 2000 A
6123398 Arai Sep 2000 A
6129718 Wada et al. Oct 2000 A
6131964 Sareshwala Oct 2000 A
6152902 Christian et al. Nov 2000 A
6164569 Hollinshead et al. Dec 2000 A
6177606 Etheredge et al. Jan 2001 B1
6209142 Mattsson et al. Apr 2001 B1
6248096 Dwork et al. Jun 2001 B1
6263887 Dunn Jul 2001 B1
6311339 Kraus Nov 2001 B1
6336919 Davis et al. Jan 2002 B1
6338729 Wada et al. Jan 2002 B1
6352525 Wakabayashi Mar 2002 B1
6394988 Hashimoto May 2002 B1
6398742 Kim Jun 2002 B1
6406463 Brown Jun 2002 B1
6409712 Dutari et al. Jun 2002 B1
6416500 Wada et al. Jul 2002 B1
6428521 Droll Aug 2002 B1
6475198 Lipman et al. Nov 2002 B1
6479726 Cole et al. Nov 2002 B1
6491673 Palumbo et al. Dec 2002 B1
6508794 Palumbo et al. Jan 2003 B1
6540729 Wada et al. Apr 2003 B1
6547771 Robertson et al. Apr 2003 B2
6569133 Cheng et al. May 2003 B2
D476518 Doppelt Jul 2003 S
6592560 Snyder et al. Jul 2003 B2
6618868 Minnick Sep 2003 B2
6620142 Flueckiger Sep 2003 B1
6629651 Male et al. Oct 2003 B1
6635038 Scovel Oct 2003 B2
6652495 Walker Nov 2003 B1
6685684 Falconer Feb 2004 B1
6702793 Sweetser et al. Mar 2004 B1
6706027 Harvie Mar 2004 B2
6732384 Scott May 2004 B2
6736977 Hall et al. May 2004 B1
6740066 Wolff May 2004 B2
6764477 Chen et al. Jul 2004 B1
6783519 Samuelsson Aug 2004 B2
6796974 Palumbo et al. Sep 2004 B2
6814547 Childers et al. Nov 2004 B2
6849065 Schmidt et al. Feb 2005 B2
6857137 Otto Feb 2005 B2
6885690 Aggerstam et al. Apr 2005 B2
6888044 Fell et al. May 2005 B2
6893425 Dunn et al. May 2005 B2
6912737 Ernest et al. Jul 2005 B2
6918899 Harvie Jul 2005 B2
6979324 Bybordi et al. Dec 2005 B2
7018366 Easter Mar 2006 B2
7066411 Male et al. Jun 2006 B2
7122023 Hinoki Oct 2006 B1
7125399 Miskie Oct 2006 B2
7131964 Harvie Nov 2006 B2
7135012 Harvie Nov 2006 B2
7141043 Harvie Nov 2006 B2
D533972 La Dec 2006 S
7160273 Greter et al. Jan 2007 B2
7171699 Ernest et al. Feb 2007 B2
7171871 Kozak Feb 2007 B2
7179951 Krishnaswamy-mirle et al. Feb 2007 B2
7181781 Trabold Feb 2007 B1
7186245 Cheng et al. Mar 2007 B1
7192424 Cooper Mar 2007 B2
7220250 Suzuki May 2007 B2
D562975 Otto Feb 2008 S
7335189 Harvie Feb 2008 B2
7358282 Krueger et al. Apr 2008 B2
7390320 Machida Jun 2008 B2
7438706 Koizumi et al. Oct 2008 B2
7488310 Yang Feb 2009 B2
7491194 Oliwa Feb 2009 B1
D591106 Dominique et al. Apr 2009 S
7513381 Heng et al. Apr 2009 B2
7520872 Biggie et al. Apr 2009 B2
D593801 Wilson et al. Jun 2009 S
7540364 Sanderson Jun 2009 B2
7585293 Vermaak Sep 2009 B2
7588560 Dunlop Sep 2009 B1
7665359 Barber Feb 2010 B2
7682347 Parks et al. Mar 2010 B2
7687004 Allen Mar 2010 B2
7695459 Gilbert et al. Apr 2010 B2
7695460 Wada et al. Apr 2010 B2
7699818 Gilbert Apr 2010 B2
7699831 Bengtson Apr 2010 B2
7722584 Tanaka et al. May 2010 B2
7727206 Gorres Jun 2010 B2
7740620 Gilbert et al. Jun 2010 B2
7749205 Tazoe Jul 2010 B2
7755497 Wada Jul 2010 B2
7766887 Burns, Jr. et al. Aug 2010 B2
D625407 Koizumi et al. Oct 2010 S
7806879 Brooks et al. Oct 2010 B2
7811272 Lindsay et al. Oct 2010 B2
7815067 Matsumoto et al. Oct 2010 B2
7833169 Hannon Nov 2010 B2
7857806 Karpowicz et al. Dec 2010 B2
7866942 Harvie Jan 2011 B2
7871385 Levinson et al. Jan 2011 B2
7875010 Frazier et al. Jan 2011 B2
7901389 Mombrinie Mar 2011 B2
7927320 Goldwasser et al. Apr 2011 B2
7927321 Marland Apr 2011 B2
7931634 Swiecicki et al. Apr 2011 B2
7939706 Okabe et al. May 2011 B2
7946443 Stull et al. May 2011 B2
7947025 Buglino et al. May 2011 B2
7963419 Burney et al. Jun 2011 B2
7976519 Bubb et al. Jul 2011 B2
7993318 Olsson et al. Aug 2011 B2
8015627 Baker et al. Sep 2011 B2
8028460 Williams Oct 2011 B2
8047398 Dimartino et al. Nov 2011 B2
8083094 Caulfield et al. Dec 2011 B2
8128608 Thevenin Mar 2012 B2
8181651 Pinel May 2012 B2
8181819 Burney et al. May 2012 B2
8211063 Bierman Jul 2012 B2
8221369 Parks et al. Jul 2012 B2
8241262 Mahnensmith Aug 2012 B2
8277426 Wilcox et al. Oct 2012 B2
8287508 Sanchez Oct 2012 B1
8303554 Tsai et al. Nov 2012 B2
8322565 Caulfield et al. Dec 2012 B2
8337477 Parks et al. Dec 2012 B2
D674241 Bickert et al. Jan 2013 S
8343122 Gorres Jan 2013 B2
8353074 Krebs Jan 2013 B2
8353886 Bester et al. Jan 2013 B2
D676241 Merrill Feb 2013 S
8388588 Wada et al. Mar 2013 B2
D679807 Burgess et al. Apr 2013 S
8425482 Khoubnazar Apr 2013 B2
8449510 Martini et al. May 2013 B2
D684260 Lund et al. Jun 2013 S
8470230 Caulfield et al. Jun 2013 B2
8479941 Matsumoto et al. Jul 2013 B2
8479949 Henkel Jul 2013 B2
8512301 Ma Aug 2013 B2
8529530 Koch et al. Sep 2013 B2
8535284 Joder et al. Sep 2013 B2
8546639 Wada Oct 2013 B2
8551075 Bengtson Oct 2013 B2
8568376 Delattre et al. Oct 2013 B2
D694404 Burgess et al. Nov 2013 S
8585683 Bengtson Nov 2013 B2
8652112 Johannison et al. Feb 2014 B2
D702973 Norland et al. Apr 2014 S
8703032 Menon et al. Apr 2014 B2
D704330 Cicatelli May 2014 S
D704510 Mason et al. May 2014 S
D705423 Walsh Cutler May 2014 S
D705926 Burgess et al. May 2014 S
8714394 Wulf May 2014 B2
8715267 Bengtson et al. May 2014 B2
8757425 Copeland Jun 2014 B2
8777032 Biesecker et al. Jul 2014 B2
8808260 Koch et al. Aug 2014 B2
8864730 Conway et al. Oct 2014 B2
8881923 Higginson Nov 2014 B2
8882731 Suzuki Nov 2014 B2
8936585 Carson et al. Jan 2015 B2
D729581 Boroski May 2015 S
9028460 Medeiros May 2015 B2
9056698 Noer Jun 2015 B2
9078792 Ruiz Jul 2015 B2
9173602 Gilbert Nov 2015 B2
9173799 Tanimoto Nov 2015 B2
9187220 Biesecker et al. Nov 2015 B2
9199772 Krippendorf Dec 2015 B2
9233020 Matsumiya Jan 2016 B2
9248058 Conway et al. Feb 2016 B2
9308118 Dupree et al. Apr 2016 B1
9309029 Incorvia et al. Apr 2016 B2
9333281 Giezendanner et al. May 2016 B2
9382047 Schmidtner et al. Jul 2016 B2
9456937 Ellis Oct 2016 B2
9480595 Baham et al. Nov 2016 B2
9517865 Albers et al. Dec 2016 B2
D777941 Piramoon Jan 2017 S
9533806 Ding et al. Jan 2017 B2
9550611 Hodge Jan 2017 B2
9555930 Campbell et al. Jan 2017 B2
9623159 Locke Apr 2017 B2
D789522 Burgess et al. Jun 2017 S
9687849 Bruno et al. Jun 2017 B2
9694949 Hendricks et al. Jul 2017 B2
9713547 Lee et al. Jul 2017 B2
9788992 Harvie Oct 2017 B2
D804907 Sandoval Dec 2017 S
9868564 Mcgirr et al. Jan 2018 B2
D814239 Arora Apr 2018 S
D817484 Lafond May 2018 S
10037640 Gordon Jul 2018 B2
10058470 Phillips Aug 2018 B2
10098990 Koch et al. Oct 2018 B2
D835264 Mozzicato et al. Dec 2018 S
D835779 Mozzicato et al. Dec 2018 S
D840533 Mozzicato et al. Feb 2019 S
D840534 Mozzicato et al. Feb 2019 S
10225376 Perez Martinez Mar 2019 B2
10226376 Sanchez Mar 2019 B2
D848612 Mozzicato et al. May 2019 S
10307305 Hodges Jun 2019 B1
10335121 Desai Jul 2019 B2
D856512 Cowart et al. Aug 2019 S
10376406 Newton Aug 2019 B2
10376407 Newton Aug 2019 B2
10390989 Sanchez Aug 2019 B2
D858144 Fu Sep 2019 S
10406039 Villarreal Sep 2019 B2
10407222 Allen Sep 2019 B2
10478356 Griffin Nov 2019 B2
10538366 Pentelovitch et al. Jan 2020 B2
10569938 Zhao et al. Feb 2020 B2
10577156 Dagnelie et al. Mar 2020 B2
10618721 Vazin Apr 2020 B2
D884390 Wang May 2020 S
10669079 Freedman et al. Jun 2020 B2
D892315 Airy Aug 2020 S
10730672 Bertram et al. Aug 2020 B2
10737848 Philip et al. Aug 2020 B2
10765854 Law et al. Sep 2020 B2
10766670 Kittmann Sep 2020 B2
10799386 Harrison Oct 2020 B1
D901214 Hu Nov 2020 S
10857025 Davis Dec 2020 B2
10865017 Cowart et al. Dec 2020 B1
10889412 West et al. Jan 2021 B2
10913581 Stahlecker Feb 2021 B2
D912244 Rehm et al. Mar 2021 S
10952889 Newton Mar 2021 B2
10973678 Newton Apr 2021 B2
10974874 Ragias et al. Apr 2021 B2
11000401 Ecklund et al. May 2021 B2
D923365 Wang Jun 2021 S
11026829 Harvie Jun 2021 B2
11027900 Liu Jun 2021 B2
11045346 Argent et al. Jun 2021 B2
D928946 Sanchez Aug 2021 S
11179506 Barr et al. Nov 2021 B2
11226376 Yamauchi et al. Jan 2022 B2
11376152 Sanchez Jul 2022 B2
11382786 Sanchez Jul 2022 B2
11382788 Hjorth et al. Jul 2022 B2
11426303 Davis Aug 2022 B2
11529252 Glithero Dec 2022 B2
20010037097 Cheng et al. Nov 2001 A1
20010054426 Knudson et al. Dec 2001 A1
20020019614 Woon Feb 2002 A1
20020026161 Grundke Feb 2002 A1
20020087131 Wolff et al. Jul 2002 A1
20020091364 Prabhakar Jul 2002 A1
20020189992 Schmidt et al. Dec 2002 A1
20020193760 Thompson Dec 2002 A1
20030004436 Schmidt et al. Jan 2003 A1
20030120178 Heki Jun 2003 A1
20030157859 Ishikawa Aug 2003 A1
20030181880 Schwartz Sep 2003 A1
20030195484 Harvie Oct 2003 A1
20030233079 Parks et al. Dec 2003 A1
20040006321 Cheng et al. Jan 2004 A1
20040056122 Male et al. Mar 2004 A1
20040084465 Luburic May 2004 A1
20040127872 Petryk et al. Jul 2004 A1
20040128749 Scott Jul 2004 A1
20040143229 Easter Jul 2004 A1
20040147894 Mizutani et al. Jul 2004 A1
20040158221 Mizutani et al. Aug 2004 A1
20040176731 Cheng et al. Sep 2004 A1
20040191919 Unger et al. Sep 2004 A1
20040207530 Nielsen Oct 2004 A1
20040236292 Tazoe Nov 2004 A1
20040254547 Okabe Dec 2004 A1
20050010182 Parks et al. Jan 2005 A1
20050033248 Machida Feb 2005 A1
20050065471 Kuntz Mar 2005 A1
20050070861 Okabe Mar 2005 A1
20050070862 Tazoe Mar 2005 A1
20050082300 Modrell et al. Apr 2005 A1
20050097662 Leimkuhler et al. May 2005 A1
20050101924 Elson et al. May 2005 A1
20050137557 Swiecicki et al. Jun 2005 A1
20050154360 Harvie Jul 2005 A1
20050177070 Levinson et al. Aug 2005 A1
20050197639 Mombrinie Sep 2005 A1
20050273920 Marinas Dec 2005 A1
20050277904 Chase et al. Dec 2005 A1
20050279359 LeBlanc et al. Dec 2005 A1
20060004332 Marx Jan 2006 A1
20060015080 Mahnensmith Jan 2006 A1
20060015081 Suzuki Jan 2006 A1
20060016778 Park Jan 2006 A1
20060079854 Kay et al. Apr 2006 A1
20060111648 Vermaak May 2006 A1
20060155214 Wightman Jul 2006 A1
20060200102 Cooper Sep 2006 A1
20060229576 Conway et al. Oct 2006 A1
20060231648 Male et al. Oct 2006 A1
20060235266 Nan Oct 2006 A1
20060235359 Marland Oct 2006 A1
20060277670 Baker et al. Dec 2006 A1
20070006368 Key et al. Jan 2007 A1
20070038194 Wada Feb 2007 A1
20070055209 Patel et al. Mar 2007 A1
20070073252 Forgrave Mar 2007 A1
20070117880 Elson et al. May 2007 A1
20070135786 Schmidt et al. Jun 2007 A1
20070149935 Dirico Jun 2007 A1
20070191804 Coley Aug 2007 A1
20070214553 Carromba Sep 2007 A1
20070225666 Otto Sep 2007 A1
20070225668 Otto Sep 2007 A1
20070266486 Ramirez Nov 2007 A1
20070282309 Bengtson et al. Dec 2007 A1
20080004576 Tanaka et al. Jan 2008 A1
20080015526 Reiner et al. Jan 2008 A1
20080015527 House Jan 2008 A1
20080033386 Okabe Feb 2008 A1
20080041869 Backaert Feb 2008 A1
20080091153 Harvie Apr 2008 A1
20080091158 Yang Apr 2008 A1
20080167634 Kouta et al. Jul 2008 A1
20080183157 Walters Jul 2008 A1
20080215031 Belfort et al. Sep 2008 A1
20080234642 Patterson et al. Sep 2008 A1
20080281282 Finger et al. Nov 2008 A1
20080287894 Van Den Heuvel Nov 2008 A1
20090025717 Pinel Jan 2009 A1
20090048570 Jensen Feb 2009 A1
20090056003 Ivie et al. Mar 2009 A1
20090069761 Vogel Mar 2009 A1
20090069765 Wortham Mar 2009 A1
20090192482 Dodge, II Jul 2009 A1
20090234312 Otoole et al. Sep 2009 A1
20090251510 Noro et al. Oct 2009 A1
20090264840 Virginio Oct 2009 A1
20090270822 Medeiros Oct 2009 A1
20090281510 Fisher Nov 2009 A1
20100004612 Thevenin Jan 2010 A1
20100058660 Williams Mar 2010 A1
20100121289 Parks et al. May 2010 A1
20100185168 Graauw Jul 2010 A1
20100198172 Wada et al. Aug 2010 A1
20100211032 Tsai Aug 2010 A1
20100234820 Tsai et al. Sep 2010 A1
20100241104 Gilbert Sep 2010 A1
20100263113 Shelton et al. Oct 2010 A1
20100310845 Bond et al. Dec 2010 A1
20110028922 Kay et al. Feb 2011 A1
20110034889 Smith Feb 2011 A1
20110036837 Shang Feb 2011 A1
20110040267 Wada Feb 2011 A1
20110040271 Rogers Feb 2011 A1
20110054426 Stewart et al. Mar 2011 A1
20110060300 Weig Mar 2011 A1
20110077495 Gilbert Mar 2011 A1
20110077606 Wilcox et al. Mar 2011 A1
20110087337 Forsell Apr 2011 A1
20110145993 Rader et al. Jun 2011 A1
20110152802 Dicamillo et al. Jun 2011 A1
20110164147 Takahashi et al. Jul 2011 A1
20110172620 Khambatta Jul 2011 A1
20110172625 Wada Jul 2011 A1
20110202024 Cozzens Aug 2011 A1
20110238023 Slayton Sep 2011 A1
20110240648 Tucker Oct 2011 A1
20110251572 Nishtala et al. Oct 2011 A1
20110265889 Tanaka et al. Nov 2011 A1
20110276020 Mitsui Nov 2011 A1
20120035577 Tomes et al. Feb 2012 A1
20120041400 Christensen Feb 2012 A1
20120059328 Dikeman et al. Mar 2012 A1
20120066825 Birbara et al. Mar 2012 A1
20120103347 Wheaton May 2012 A1
20120137420 Gordon et al. Jun 2012 A1
20120165768 Sekiyama et al. Jun 2012 A1
20120165786 Chappa et al. Jun 2012 A1
20120210503 Anzivino, Sr. Aug 2012 A1
20120233761 Huang Sep 2012 A1
20120245541 Suzuki Sep 2012 A1
20120245542 Suzuki Sep 2012 A1
20120245547 Wilcox et al. Sep 2012 A1
20120253303 Suzuki Oct 2012 A1
20120271259 Ulert Oct 2012 A1
20120296305 Barraza Khaled et al. Nov 2012 A1
20120330256 Wilcox et al. Dec 2012 A1
20130006206 Wada Jan 2013 A1
20130045651 Esteves et al. Feb 2013 A1
20130053804 Soerensen et al. Feb 2013 A1
20130096523 Chang et al. Apr 2013 A1
20130245496 Wells et al. Sep 2013 A1
20130245586 Jha Sep 2013 A1
20130292537 Dirico Nov 2013 A1
20140031774 Bengtson Jan 2014 A1
20140157499 Suzuki et al. Jun 2014 A1
20140171889 Hopman et al. Jun 2014 A1
20140182051 Tanimoto Jul 2014 A1
20140196189 Lee et al. Jul 2014 A1
20140303582 Wright et al. Oct 2014 A1
20140316381 Reglin Oct 2014 A1
20140325746 Block Nov 2014 A1
20140348139 Gomez Martinez Nov 2014 A1
20140352050 Yao et al. Dec 2014 A1
20140371628 Desai Dec 2014 A1
20150045757 Lee et al. Feb 2015 A1
20150047114 Ramirez Feb 2015 A1
20150048089 Robertson Feb 2015 A1
20150135423 Sharpe et al. May 2015 A1
20150157300 Ealovega et al. Jun 2015 A1
20150209194 Heyman Jul 2015 A1
20150290425 Macy et al. Oct 2015 A1
20150320583 Harvie Nov 2015 A1
20150329255 Rzepecki Nov 2015 A1
20150359660 Harvie Dec 2015 A1
20150366699 Nelson Dec 2015 A1
20160029998 Brister et al. Feb 2016 A1
20160030228 Jones Feb 2016 A1
20160038356 Yao et al. Feb 2016 A1
20160058322 Brister et al. Mar 2016 A1
20160060001 Wada et al. Mar 2016 A1
20160100976 Conway et al. Apr 2016 A1
20160106604 Timm Apr 2016 A1
20160113809 Kim Apr 2016 A1
20160183689 Miner Jun 2016 A1
20160256022 Le Sep 2016 A1
20160270982 Raycheck et al. Sep 2016 A1
20160278662 Brister et al. Sep 2016 A1
20160357400 Penha et al. Dec 2016 A1
20160366699 Zhang et al. Dec 2016 A1
20160367226 Newton Dec 2016 A1
20160367411 Justiz et al. Dec 2016 A1
20160374848 Sanchez Dec 2016 A1
20170007438 Harvie Jan 2017 A1
20170014560 Minskoff et al. Jan 2017 A1
20170100276 Joh Apr 2017 A1
20170128638 Giezendanner et al. May 2017 A1
20170143534 Sanchez May 2017 A1
20170165405 Muser et al. Jun 2017 A1
20170189225 Voorhees et al. Jul 2017 A1
20170202692 Laniado Jul 2017 A1
20170216081 Accosta Aug 2017 A1
20170246026 Laniado Aug 2017 A1
20170252014 Siller Gonzalez et al. Sep 2017 A1
20170252202 Sanchez et al. Sep 2017 A9
20170266031 Sanchez Sep 2017 A1
20170266658 Bruno et al. Sep 2017 A1
20170281399 VanMiddendorp Oct 2017 A1
20170312116 Laniado Nov 2017 A1
20170325788 Ealovega et al. Nov 2017 A1
20170333244 Laniado Nov 2017 A1
20170042748 Griffin Dec 2017 A1
20170348139 Newton Dec 2017 A1
20170354532 Holt Dec 2017 A1
20170367873 Grannum Dec 2017 A1
20180002075 Lee Jan 2018 A1
20180008451 Stroebech Jan 2018 A1
20180008804 Laniado Jan 2018 A1
20180028349 Newton Feb 2018 A1
20180037384 Archeny et al. Feb 2018 A1
20180049910 Newton Feb 2018 A1
20180064572 Wiltshire Mar 2018 A1
20180104131 Killian Apr 2018 A1
20180127187 Sewell May 2018 A1
20180193215 Davies et al. Jul 2018 A1
20180200101 Su Jul 2018 A1
20180228642 Davis Aug 2018 A1
20180256384 Kasirye Sep 2018 A1
20180271694 Fernandez et al. Sep 2018 A1
20180317892 Catlin Nov 2018 A1
20190001030 Braga et al. Jan 2019 A1
20190021899 Vlet Jan 2019 A1
20190038451 Harvie Feb 2019 A1
20190046102 Kushnir et al. Feb 2019 A1
20190100362 Meyers et al. Apr 2019 A1
20190133814 Tammen et al. May 2019 A1
20190142624 Sanchez May 2019 A1
20190224036 Sanchez Jul 2019 A1
20190247222 Ecklund et al. Aug 2019 A1
20190247223 Brun et al. Aug 2019 A1
20190282391 Johannes et al. Sep 2019 A1
20190314189 Acosta Oct 2019 A1
20190314190 Sanchez Oct 2019 A1
20190344934 Faerber et al. Nov 2019 A1
20190365307 Laing et al. Dec 2019 A1
20190365561 Newton et al. Dec 2019 A1
20200008985 Nguyen et al. Jan 2020 A1
20200030595 Boukidjian et al. Jan 2020 A1
20200046544 Godinez Feb 2020 A1
20200055638 Lau et al. Feb 2020 A1
20200070392 Huber et al. Mar 2020 A1
20200085610 Cohn et al. Mar 2020 A1
20200086090 Von Weymarn-schärli et al. Mar 2020 A1
20200129322 Leuckel Apr 2020 A1
20200171217 Braga et al. Jun 2020 A9
20200229964 Staali et al. Jul 2020 A1
20200231343 Freedman et al. Jul 2020 A1
20200232841 Satish et al. Jul 2020 A1
20200255189 Liu Aug 2020 A1
20200261280 Heyman Aug 2020 A1
20200276046 Staali et al. Sep 2020 A1
20200306075 Newton et al. Oct 2020 A1
20200315838 Eckert Oct 2020 A1
20200331672 Bertram et al. Oct 2020 A1
20200345332 Duval Nov 2020 A1
20200353135 Gregory et al. Nov 2020 A1
20200367677 Silsby et al. Nov 2020 A1
20200369444 Silsby et al. Nov 2020 A1
20200375781 Staali et al. Dec 2020 A1
20200385179 Mccourt Dec 2020 A1
20200390591 Glithero Dec 2020 A1
20200390592 Merrill Dec 2020 A1
20200405521 Glasroe Dec 2020 A1
20210008771 Huber et al. Jan 2021 A1
20210009323 Markarian et al. Jan 2021 A1
20210059853 Davis Mar 2021 A1
20210061523 Bytheway Mar 2021 A1
20210069005 Sanchez Mar 2021 A1
20210069008 Blabas et al. Mar 2021 A1
20210077993 Nazareth et al. Mar 2021 A1
20210113749 Radl et al. Apr 2021 A1
20210121318 Pinlac Apr 2021 A1
20210137724 Ecklund et al. May 2021 A1
20210154055 Villarreal May 2021 A1
20210170079 Radl et al. Jun 2021 A1
20210220162 Jamison Jul 2021 A1
20210220163 Mayrand Jul 2021 A1
20210228400 Glithero Jul 2021 A1
20210228401 Becker et al. Jul 2021 A1
20210228795 Hughett Jul 2021 A1
20210229877 Ragias et al. Jul 2021 A1
20210236323 Austermann Aug 2021 A1
20210267787 Nazemi Sep 2021 A1
20210275343 Sanchez Sep 2021 A1
20210315727 Jiang Oct 2021 A1
20210353450 Sharma et al. Nov 2021 A1
20210361469 Liu et al. Nov 2021 A1
20210369495 Cheng Dec 2021 A1
20210386925 Hartwell et al. Dec 2021 A1
20210393433 Godinez et al. Dec 2021 A1
20220023091 Ecklund et al. Jan 2022 A1
20220047410 Walthall Feb 2022 A1
20220062027 Mitchell et al. Mar 2022 A1
20220062029 Johannes Mar 2022 A1
20220066825 Saraf et al. Mar 2022 A1
20220071811 Cheng Mar 2022 A1
20220071826 Kulkarni et al. Mar 2022 A1
20220104965 Vaninetti et al. Apr 2022 A1
20220104981 Jones Apr 2022 A1
20220117774 Meyer Apr 2022 A1
20220117775 Jones Apr 2022 A1
20220133524 Davis May 2022 A1
20220151817 Mann May 2022 A1
20220218510 Metzger et al. Jul 2022 A1
20220229053 Levin et al. Jul 2022 A1
20220248836 Cagle et al. Aug 2022 A1
20220257407 Johannes Aug 2022 A1
20220265462 Alder Aug 2022 A1
20220273482 Johannes et al. Sep 2022 A1
20220280357 Jagannathan Sep 2022 A1
20220313474 Kriscovich et al. Oct 2022 A1
20220354685 Davis Nov 2022 A1
20220370231 Wang et al. Nov 2022 A1
20220370234 Hughett et al. Nov 2022 A1
20220370237 Parmar et al. Nov 2022 A1
20220387001 Askenazi et al. Dec 2022 A1
20220395391 Saunders et al. Dec 2022 A1
20230018845 Lee Jan 2023 A1
20230020563 Sharma et al. Jan 2023 A1
20230037159 Brennan et al. Feb 2023 A1
20230062994 Ecklund et al. Mar 2023 A1
20230089032 Hughett et al. Mar 2023 A1
20230105001 Whittome et al. Apr 2023 A1
20230138269 Abdelal et al. May 2023 A1
20230145365 Martin et al. May 2023 A1
20230277362 Davis Sep 2023 A1
Foreign Referenced Citations (331)
Number Date Country
2018216821 Aug 2019 AU
2165286 Sep 1999 CA
2354132 Jun 2000 CA
2488867 Aug 2007 CA
3050918 Aug 2018 CA
3098571 Nov 2019 CA
2269203 Dec 1997 CN
1332620 Jan 2002 CN
1533755 Oct 2004 CN
1602825 Apr 2005 CN
1720888 Jan 2006 CN
2006026108 Feb 2006 CN
2936204 Aug 2007 CN
101262836 Sep 2008 CN
102159159 Aug 2011 CN
202184840 Apr 2012 CN
102481441 May 2012 CN
103533968 Jan 2014 CN
103717180 Apr 2014 CN
204562697 Aug 2015 CN
105451693 Mar 2016 CN
205849719 Jan 2017 CN
107847384 Mar 2018 CN
107920912 Apr 2018 CN
209285902 Aug 2019 CN
211198839 Aug 2020 CN
114375187 Apr 2022 CN
116096332 May 2023 CN
1516466 Jun 1969 DE
2721330 Nov 1977 DE
2742298 Mar 1978 DE
9407554.9 May 1995 DE
4443710 Jun 1995 DE
19619597 Nov 1997 DE
102011103783 Dec 2012 DE
202015104597 Jul 2016 DE
9600118 Nov 1996 DK
0032138 Jul 1981 EP
0066070 Dec 1982 EP
0274753 Jul 1988 EP
0119143 Nov 1988 EP
0610638 Aug 1994 EP
0613355 Sep 1994 EP
0613355 Jan 1997 EP
0966936 Dec 1999 EP
0987293 Mar 2000 EP
1063953 Jan 2001 EP
0653928 Oct 2002 EP
1332738 Aug 2003 EP
1382318 Jan 2004 EP
1089684 Oct 2004 EP
1616542 Jan 2006 EP
1382318 May 2006 EP
1063953 Jan 2007 EP
1872752 Jan 2008 EP
2180907 May 2010 EP
2380532 Oct 2011 EP
2389908 Nov 2011 EP
2601916 Jun 2013 EP
2676643 Dec 2013 EP
2997950 Mar 2016 EP
2879534 Mar 2017 EP
3424471 Jan 2019 EP
3169292 Nov 2019 EP
3788992 Mar 2021 EP
3576689 Mar 2022 EP
3752110 Mar 2022 EP
4025163 Jul 2022 EP
1011517 Dec 1965 GB
1467144 Mar 1977 GB
2106395 Apr 1983 GB
2106784 Apr 1983 GB
2148126 May 1985 GB
2171315 Aug 1986 GB
2148126 Jul 1987 GB
2191095 Dec 1987 GB
2199750 Jul 1988 GB
2260907 May 1993 GB
2462267 Feb 2010 GB
2469496 Oct 2010 GB
2490327 Oct 2012 GB
2507318 Apr 2014 GB
201800009129 Apr 2020 IT
S5410596 Jan 1979 JP
S5410596 May 1979 JP
S55155618 Dec 1980 JP
S5888596 Jun 1983 JP
S63107780 Jul 1988 JP
H0267530 Mar 1990 JP
H02103871 Apr 1990 JP
H02131422 May 1990 JP
H0460220 Feb 1992 JP
H05123349 May 1993 JP
H05123350 May 1993 JP
H085630 Jan 1996 JP
H1040141 Feb 1998 JP
H10225430 Aug 1998 JP
H11113946 Apr 1999 JP
H11290365 Oct 1999 JP
2000116690 Apr 2000 JP
2000185068 Jul 2000 JP
3087938 Sep 2000 JP
2001054531 Feb 2001 JP
2001070331 Mar 2001 JP
2001276107 Oct 2001 JP
2001276108 Oct 2001 JP
2002028173 Jan 2002 JP
2003505152 Feb 2003 JP
2003180722 Jul 2003 JP
2004130056 Apr 2004 JP
2004267530 Sep 2004 JP
2005066011 Mar 2005 JP
2005066325 Mar 2005 JP
2005518237 Jun 2005 JP
3749097 Dec 2005 JP
3123547 Jun 2006 JP
2006136492 Jun 2006 JP
2006204868 Aug 2006 JP
2007044494 Feb 2007 JP
3132659 May 2007 JP
4039641 Nov 2007 JP
2009509570 Mar 2009 JP
2009101738 Aug 2009 JP
2010081981 Apr 2010 JP
4640772 Dec 2010 JP
2010536439 Dec 2010 JP
4747166 May 2011 JP
2011087823 May 2011 JP
4801218 Aug 2011 JP
2011218130 Nov 2011 JP
2011224070 Nov 2011 JP
2012523869 Oct 2012 JP
2013238608 Nov 2013 JP
2014521960 Aug 2014 JP
2015092945 May 2015 JP
3198994 Jul 2015 JP
2019525811 Sep 2019 JP
2021120686 Aug 2021 JP
200290061 Sep 2002 KR
20030047451 Jun 2003 KR
20140039485 Apr 2014 KR
101432639 Aug 2014 KR
20180106659 Oct 2018 KR
20180108774 Oct 2018 KR
2068717 Jun 2013 PT
8101957 Jul 1981 WO
8804558 Jun 1988 WO
9104714 Apr 1991 WO
9104714 Jun 1991 WO
9220299 Feb 1993 WO
9309736 May 1993 WO
9309736 Jun 1993 WO
9514448 Jun 1995 WO
9600096 Jan 1996 WO
9634636 Nov 1996 WO
9817211 Apr 1998 WO
9830336 Jul 1998 WO
0000112 Jan 2000 WO
0000113 Jan 2000 WO
0025651 May 2000 WO
0033773 Jun 2000 WO
0057784 Oct 2000 WO
0145618 Jun 2001 WO
0145621 Jun 2001 WO
02094160 Nov 2002 WO
03013967 Feb 2003 WO
03024824 Mar 2003 WO
03055423 Jul 2003 WO
03071931 Sep 2003 WO
03079942 Oct 2003 WO
03071931 Feb 2004 WO
2004019836 Mar 2004 WO
2004024046 Mar 2004 WO
2005074571 Sep 2005 WO
2005089687 Sep 2005 WO
2005107661 Nov 2005 WO
2006021220 Mar 2006 WO
2007007845 Jan 2007 WO
2007042823 Apr 2007 WO
2007055651 May 2007 WO
2006098950 Nov 2007 WO
2007128156 Feb 2008 WO
2008026106 Mar 2008 WO
2008078117 Jul 2008 WO
2008104019 Sep 2008 WO
2008141471 Nov 2008 WO
2009004368 Jan 2009 WO
2009004369 Jan 2009 WO
2009052496 Apr 2009 WO
2009007702 Jul 2009 WO
2010058192 May 2010 WO
2010030122 Jul 2010 WO
2010101915 Jan 2011 WO
2011018132 Feb 2011 WO
2011018133 Feb 2011 WO
201 1024864 Mar 2011 WO
2011054118 May 2011 WO
2011079132 Jun 2011 WO
2011107972 Sep 2011 WO
2011108972 Sep 2011 WO
2011117292 Sep 2011 WO
2011123219 Oct 2011 WO
2011132043 Oct 2011 WO
2012012908 Feb 2012 WO
2012065274 May 2012 WO
2012097462 Jul 2012 WO
2012098796 Jul 2012 WO
2012101288 Aug 2012 WO
2012175916 Dec 2012 WO
2013018435 Feb 2013 WO
2013033429 Mar 2013 WO
2013055434 Apr 2013 WO
2013082397 Jun 2013 WO
2013103291 Jul 2013 WO
2013131109 Sep 2013 WO
2013167478 Nov 2013 WO
2013177716 Dec 2013 WO
2014041534 Mar 2014 WO
2014046420 Mar 2014 WO
2014118518 Aug 2014 WO
2014160852 Oct 2014 WO
2015023599 Feb 2015 WO
2015052348 Apr 2015 WO
2015068384 May 2015 WO
2015169403 Nov 2015 WO
2015170307 Nov 2015 WO
2015197462 Dec 2015 WO
2016051385 Apr 2016 WO
2016055989 Apr 2016 WO
2016071894 May 2016 WO
2016103242 Jun 2016 WO
2016116915 Jul 2016 WO
2016124203 Aug 2016 WO
2016139448 Sep 2016 WO
2016166562 Oct 2016 WO
2016167535 Oct 2016 WO
2016191574 Dec 2016 WO
2016200088 Dec 2016 WO
2016200361 Dec 2016 WO
2016204731 Dec 2016 WO
2017075226 May 2017 WO
2017152198 Sep 2017 WO
2017153357 Sep 2017 WO
2017162559 Sep 2017 WO
2017205446 Nov 2017 WO
2017209779 Dec 2017 WO
2017210524 Dec 2017 WO
2018022414 Feb 2018 WO
2018044781 Mar 2018 WO
2018056953 Mar 2018 WO
2018090550 May 2018 WO
2018138513 Aug 2018 WO
2018144318 Aug 2018 WO
2018144463 Aug 2018 WO
2018150263 Aug 2018 WO
2018150268 Aug 2018 WO
2018152156 Aug 2018 WO
2018183791 Oct 2018 WO
2018150267 Nov 2018 WO
2018235026 Dec 2018 WO
2018235065 Dec 2018 WO
2019004404 Jan 2019 WO
2019065541 Apr 2019 WO
2019096845 May 2019 WO
2019150385 Aug 2019 WO
2019161094 Aug 2019 WO
2019188566 Oct 2019 WO
2019190593 Oct 2019 WO
2019212949 Nov 2019 WO
2019212950 Nov 2019 WO
2019212951 Nov 2019 WO
2019212952 Nov 2019 WO
2019212954 Nov 2019 WO
2019212955 Nov 2019 WO
2019212956 Nov 2019 WO
2019214787 Nov 2019 WO
2019214788 Nov 2019 WO
2020000994 Jan 2020 WO
2020020618 Jan 2020 WO
2020038822 Feb 2020 WO
2020088409 May 2020 WO
2020049394 Jun 2020 WO
2020120657 Jun 2020 WO
2020152575 Jul 2020 WO
2020182923 Sep 2020 WO
2020204967 Oct 2020 WO
2020209898 Oct 2020 WO
2020242790 Dec 2020 WO
2020251893 Dec 2020 WO
2020256865 Dec 2020 WO
2021007144 Jan 2021 WO
2021007345 Jan 2021 WO
2021010844 Jan 2021 WO
2021016026 Jan 2021 WO
2021016300 Jan 2021 WO
2021025919 Feb 2021 WO
2021034886 Feb 2021 WO
2021041123 Mar 2021 WO
2021086868 May 2021 WO
2021094352 May 2021 WO
2021102296 May 2021 WO
2021138411 Jul 2021 WO
2021138414 Jul 2021 WO
2021155206 Aug 2021 WO
2021173436 Sep 2021 WO
2021195384 Sep 2021 WO
2021207621 Oct 2021 WO
2021211568 Oct 2021 WO
2021216419 Oct 2021 WO
2021216422 Oct 2021 WO
2021247523 Dec 2021 WO
2021257202 Dec 2021 WO
2022006256 Jan 2022 WO
2022031943 Feb 2022 WO
2022035745 Feb 2022 WO
2022076427 Apr 2022 WO
2022086898 Apr 2022 WO
2022098536 May 2022 WO
2022125685 Jun 2022 WO
2022140545 Jun 2022 WO
2022150360 Jul 2022 WO
2022150463 Jul 2022 WO
2022159392 Jul 2022 WO
2022170182 Aug 2022 WO
2022182385 Sep 2022 WO
2022192188 Sep 2022 WO
2022192347 Sep 2022 WO
2023014641 Feb 2023 WO
2023038945 Mar 2023 WO
2023038950 Mar 2023 WO
2023049175 Mar 2023 WO
Non-Patent Literature Citations (577)
Entry
US 9,908,683 B2, 03/2018, Sandhausen et al. (withdrawn)
Advisory Action for U.S. Appl. No. 16/905,400 dated Jun. 9, 2021.
Final Office Action for U.S. Appl. No. 16/899,956 dated Apr. 19, 2021.
Final Office Action for U.S. Appl. No. 16/905,400 dated Apr. 6, 2021.
Final Office Action for U.S. Appl. No. 17/088,272 dated May 25, 2021.
Notice of Allowance for U.S. Appl. No. 14/952,591 dated Apr. 5, 2021.
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Apr. 28, 2021.
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Apr. 29, 2021.
Restriction Requirement for U.S. Appl. No. 16/478,180 dated May 25, 2021.
U.S. Appl. No. 17/330,657 dated May 26, 2021
Boehringer CareDry System—Second Generation for Non-Invasive Urinary Management for Females, Mar. 2021, 3 pgs.
Advisory Action for U.S. Appl. No. 14/722,613 dated Mar. 4, 2019.
Advisory Action for U.S. Appl. No. 14/952,591 dated Jun. 1, 2018.
Advisory Action for U.S. Appl. No. 15/238,427 dated Apr. 10, 2019.
Corrected International Search Report and Written Opinion for International Application No. PCT/US2017/043025 dated Jan. 11, 2018.
Corrected Notice of Allowability for U.S. Appl. No. 15/221,106 dated Jul. 2, 2019.
Final Office Action for U.S. Appl. No. 14/722,613 dated Nov. 29, 2018.
Final Office Action for U.S. Appl. No. 14/947,759 dated Apr. 8, 2016.
Final Office Action for U.S. Appl. No. 14/952,591 dated Feb. 23, 2018.
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 1, 2019.
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 27, 2020.
Final Office Action for U.S. Appl. No. 15/171,968 dated Feb. 14, 2020.
Final Office Action for U.S. Appl. No. 15/171,968 dated Mar. 19, 2019.
Final Office Action for U.S. Appl. No. 15/221,106 dated Jan. 23, 2019.
Final Office Action for U.S. Appl. No. 15/238,427 dated Jan. 2, 2019.
Final Office Action for U.S. Appl. No. 15/260,103 dated Feb. 14, 2019.
Final Office Action for U.S. Appl. No. 15/612,325 dated Sep. 17, 2020.
Final Office Action for U.S. Appl. No. 29/624,661 dated Feb. 18, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2016/049274 dated Dec. 1, 2016.
International Search Report and Written Opinion from International Application No. PCT/US2017/035625 dated Aug. 15, 2017.
International Search Report and Written Opinion from International Application No. PCT/US2017/043025 dated Oct. 18, 2017.
International Search Report and Written Opinion from International Application No. PCT/US2018/015968 dated Apr. 6, 2018.
International Search Report and Written Opinion from International Application No. PCT/US2019/029608 dated Sep. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029609 dated Sep. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029610 dated Sep. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029611 dated Jul. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029613 dated Jul. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029614 dated Sep. 26, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029616 dated Aug. 30, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2020/023572 dated Jul. 6, 2020.
Issue Notification for U.S. Appl. No. 15/221,106 dated Jul. 24, 2019.
Issue Notification for U.S. Appl. No. 15/238,427 dated Jul. 24, 2019.
Issue Notification for U.S. Appl. No. 15/260,103 dated Aug. 7, 2019.
Issue Notification for U.S. Appl. No. 15/611,587 dated Feb. 20, 2019.
Non-Final Office Action for U.S. Appl. No. 14/722,613 dated Jun. 13, 2019.
Non-Final Office Action for U.S. Appl. No. 14/947,759, dated Mar. 17, 2016.
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Aug. 1, 2017.
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 20, 2020.
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 21, 2019.
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Sep. 28, 2018.
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated May 11, 2020.
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Aug. 20, 2019.
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Jun. 12, 2018.
Non-Final Office Action for U.S. Appl. No. 15/221,106 dated Jun. 5, 2018.
Non-Final Office Action for U.S. Appl. No. 15/238,427 dated Aug. 8, 2018.
Non-Final Office Action for U.S. Appl. No. 15/260,103 dated Sep. 26, 2018.
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Dec. 29, 2017.
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Jul. 13, 2018.
Non-Final Office Action for U.S. Appl. No. 15/612,325 dated Mar. 19, 2020.
Non-Final Office Action for U.S. Appl. No. 16/899,956 dated Oct. 16, 2020.
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Nov. 25, 2020.
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Dec. 2, 2020.
Non-Final Office Action for U.S. Appl. No. 29/624,661 dated Jul. 18, 2019.
Non-Final Office Action for U.S. Appl. No. 29/694,002 dated Jun. 24, 2020.
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Nov. 6, 2020.
Notice of Allowance for U.S. Appl. No. 15/221,106 dated May 1, 2019.
Notice of Allowance for U.S. Appl. No. 15/238,427 dated May 23, 2019.
Notice of Allowance for U.S. Appl. No. 15/260,103 dated Jun. 7, 2019.
Notice of Allowance for U.S. Appl. No. 15/611,587 dated Dec. 21, 2018.
Notice of Allowance for U.S. Appl. No. 15/612,325 dated Jan. 21, 2021.
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Jul. 10, 2020.
Notice of Allowance for U.S. Appl. No. 29/624,661 dated May 14, 2020.
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Sep. 29, 2020.
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Oct. 16, 2020.
U.S. Appl. No. 15/171,968, filed Jun. 2, 2016.
U.S. Appl. No. 15/221,106, filed Jul. 27, 2016.
U.S. Appl. No. 15/260,103, filed Sep. 8, 2016.
U.S. Appl. No. 15/611,587, filed Jun. 1, 2017.
U.S. Appl. No. 15/612,325, filed Jun. 2, 2017.
U.S. Appl. No. 16/369,676, filed Mar. 29, 2019.
U.S. Appl. No. 16/433,773, filed Jun. 6, 2019.
U.S. Appl. No. 16/449,039, filed Jun. 21, 2019.
U.S. Appl. No. 16/452,145, filed Jun. 25, 2019.
U.S. Appl. No. 16/452,258, filed Jun. 25, 2019.
U.S. Appl. No. 16/478,180, filed Jul. 16, 2019.
U.S. Appl. No. 16/904,868, filed Jun. 18, 2020.
U.S. Appl. No. 16/905,400, filed Jun. 18, 2020.
U.S. Appl. No. 17/051,550, filed Oct. 29, 2020.
U.S. Appl. No. 17/051,585, filed Oct. 29, 2020.
U.S. Appl. No. 17/051,600, filed Oct. 29, 2020.
U.S. Appl. No. 17/088,272, filed Nov. 3, 2020.
U.S. Appl. No. 29/741,751, filed Jul. 15, 2020.
U.S. Appl. No. 62/452,437, filed Jan. 31, 2017.
U.S. Appl. No. 62/665,297, filed May 1, 2018.
U.S. Appl. No. 62/665,302, filed May 1, 2018.
U.S. Appl. No. 62/665,317, filed May 1, 2018.
U.S. Appl. No. 62/665,321, filed May 1, 2018.
U.S. Appl. No. 62/665,331, filed May 1, 2018.
U.S. Appl. No. 62/665,335, filed May 1, 2018.
U.S. Appl. No. 62/853,889, filed May 29, 2019.
U.S. Appl. No. 62/873,045, filed Jul. 11, 2019.
U.S. Appl. No. 62/873,048, filed Jul. 11, 2019.
U.S. Appl. No. 62/994,912, filed Mar. 26, 2020.
U.S. Appl. No. 63/011,445, filed Apr. 17, 2020.
U.S. Appl. No. 63/011,487, filed Apr. 17, 2020.
U.S. Appl. No. 63/011,571, filed Apr. 17, 2020.
U.S. Appl. No. 63/011,657, filed Apr. 17, 2020.
U.S. Appl. No. 63/011,760, filed Apr. 17, 2020.
U.S. Appl. No. 63/012,347, filed Apr. 20, 2020.
U.S. Appl. No. 63/012,384, filed Apr. 20, 2020.
U.S. Appl. No. 63/061,241, filed Aug. 5, 2020.
U.S. Appl. No. 63/061,244, filed Aug. 5, 2020.
U.S. Appl. No. 63/061,834, filed Aug. 6, 2020.
U.S. Appl. No. 63/064,017, filed Aug. 11, 2020.
U.S. Appl. No. 63/064,126 filed Aug. 11, 2020.
U.S. Appl. No. 63/071,438, filed Aug. 28, 2020.
U.S. Appl. No. 63/074,051, filed Sep. 3, 2020.
U.S. Appl. No. 63/074,066, filed Sep. 3, 2020.
U.S. Appl. No. 63/076,032, filed Sep. 9, 2020.
U.S. Appl. No. 63/076,474, filed Sep. 10, 2020.
U.S. Appl. No. 63/076,477, filed Sep. 10, 2020.
U.S. Appl. No. 63/082,261, filed Sep. 23, 2020.
U.S. Appl. No. 63/088,506, filed Oct. 7, 2020.
U.S. Appl. No. 63/088,511, filed Oct. 7, 2020.
U.S. Appl. No. 63/094,464, filed Oct. 21, 2020.
U.S. Appl. No. 63/094,594, filed Oct. 21, 2020.
U.S. Appl. No. 63/094,608, filed Oct. 21, 2020.
U.S. Appl. No. 63/094,626, filed Oct. 21, 2020.
Defendant and Counterclaim Plaintiff Sage Products, LLC's Answer, Defenses, and Counterclaims to Plaintiff's Amended Complaint, Nov. 1, 2019.
Sage's Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; and 10,390,989, May 29, 2020, 193 pages.
Sage's Supplemental and Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; 10,390,989 and Initial Invalidity Contentions Regarding U.S. Pat. No. 10,376,407, Aug. 21, 2020, 277 pages.
Sage's Second Supplemental Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508, 10,226,375, 10,390,989, and 10,376,407, 292 pages.
Excerpts from the 508 (U.S. Pat. No. 8,278,508) Patent's Prosecution History, 2020, 99 pages.
Plaintiff's Opening Claim Construction Brief, Case No. 19-1508-MN, Oct. 16, 2020, 26 pages.
Plaintiff's Identification of Claim Terms and Proposed Constructions, Case No. 19-1508-MN, 3 pages.
PureWick's Response to Interrogatory No. 9 in PureWick, LLC v. Sage Products, LLC, Case No. 19-1508-MN, Mar. 23, 2020, 6 pages.
Sage's Preliminary Identification of Claim Elements and Proposed Constructions for U.S. Pat. Nos. 8,287,508, 10,226,376, 10,390,989 and 10,376,407, Case No. 19-1508-MN, 7 pages.
Corrected Certificate of Service, Case No. IPR2020-01426, U.S. Pat. No. 8,287,508, 2020, 2 pages.
Declaration of Diane K. Newman Curriculum Vitae, Petition for Interparties Review, 2020, pp. 1-199.
“3 Devices Take Top Honors in Dare-To-Dream Medtech Design Contest”, R+D Digest, Nov. 2013, 1 page.
“Advanced Mission Extender Device (AMDX) Products”, Omni Medical Systems, Inc., 15 pages.
“AMXD Control Starter Kit Brochure”, https://www.omnimedicalsys.com/index.php?page=products, Omni Medical, 8 pages.
“AMXDmax In-Flight Bladder Relief”, Omni Medical; Omni Medical Systems, Inc., 2015.
“AMXDX—Advanced Mission Extender Device Brochure”, Omni Medical, Omni Brochure—http://www.omnimedicalsys.com/uploads/AMXDFixedWing.pdf, 2 pages.
“How Period Panties Work”, www.shethinx.com/pages/thinx-itworks, 2020, 10 pages.
“In Flight Bladder Relief”, Omni Medical, Omni Presentation https://www.omnimedicalsys.com/uploads/AMXDmax_HSD.pdf, 14 pages.
“Research and Development Work Relating to Assistive Technology Jun. 2005”, British Department of Health, Nov. 2006, 40 pages.
“Step by Step How Ur24 WorksHome”, http://medicalpatentur24.com, last accessed Dec. 6, 2017, Aug. 30, 2017, 4 pages.
“Underwear that absorbs your period”, Thinx!, https://www.shethinx.com/pages/thinx-it-works last accessed Jun. 24, 2020, 7 pages.
“User & Maintenance Guide”, Omni Medical, 2007, 16 pages.
“Winners Announced for Dare-to-Dream Medtech Design Challenge”, https://www.mddionline.com/design-engineering/winners-announced-dare-dream-medtech-design-challenge, MD&DI, 2014, 4 pages.
Hollister, Female Urinary and Pouch and Male Urinary Pouch Brochure, 2011, 1 page.
Hollister, “Male Urinary Pouch External Collection Device”, http://www.hollister.com/en/products/Continence-Care-Products/Urine-Collectors/Urine-Collection-Accessories/Male-Urinary-Pouch-External-Collection-Device, last accessed Feb. 8, 2018.
Hollister, “Retracted Penis Pouch by Hollister”, Vitality Medical.com, https://www.vitalitymedical.com/hollister-retracted-penis-pouch.html last accessed Jun. 24, 2020, 6 pages.
Macaulay, et al., “A Noninvasive Continence Management System: Development and Evaluation of a Novel Toileting Device for Women”, The Wound, Ostomy and Continence Nurses Society, vol. 34 No. 6, 2007, pp. 641-648.
Newman, et al., “The Urinary Incontinence Sourcebook”, Petition for Interparties Review, 1997, 23 pages.
Newton, et al., “Measuring Safety, Effectiveness and Ease of Use of PureWick in the Management of Urinary Incontinence in Bedbound Women: Case Studies”, Jan. 8, 2016, 11 pages.
Parmar, “10 Finalists Chosen for Dare-to-Dream Medtech Design Challenge (PureWick)”, Design Services, Nov. 10, 2014, 3 pages.
Purewick, “Incontinence Relief for Women”, Presentation, Sep. 23, 2015, 7 pages.
Pytlik, “Super Absorbent Polymers”, University of Buffalo, http://www.courses.sens.buffalo.edu/ce435/Diapers/Diapers.html, accessed on Feb. 17, 2017.
Sachtman, “New Relief for Pilots? It Depends”, Wired, https://www.wired.com/2008/05/pilot-relief/, 2008, 2 pages.
Corrected Notice of Allowability for U.S. Appl. No. 15/612,325 dated Mar. 17, 2021.
Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 26, 2021.
Issue Notification for U.S. Appl. No. 15/171,968 dated Mar. 3, 2021.
Issue Notification for U.S. Appl. No. 15/612,325 dated Mar. 24, 2021.
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Feb. 16, 2021.
Notice of Allowance for U.S. Appl. No. 15/612,325 dated Feb. 19, 2021.
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Jan. 29, 2021.
Notice to File Missing Parts for U.S. Appl. No. 17/179,116 dated Mar. 3, 2021.
U.S. Appl. No. 17/179,116, filed Feb. 18, 2021.
Memorandum Order, Feb. 2021, 14 pgs.
Decision Granting Institution of Inter Partes Review for U.S. Pat. No. 8,287,508, Case No. 2020-01426, Feb. 17, 2021, 39 pages.
Advisory Action for U.S. Appl. No. 16/245,726 dated Apr. 19, 2023.
Advisory Action for U.S. Appl. No. 16/369,676 dated Mar. 24, 2023.
Advisory Action for U.S. Appl. No. 16/433,773 dated Feb. 15, 2023.
Advisory Action for U.S. Appl. No. 16/452,258 dated Oct. 26, 2022.
Advisory Action for U.S. Appl. No. 16/478,180 dated Sep. 21, 2022.
Advisory Action for U.S. Appl. No. 16/478,180 dated Sep. 7, 2023.
Advisory Action for U.S. Appl. No. 16/899,956 dated Jul. 9, 2021.
Advisory Action for U.S. Appl. No. 16/904,868 dated Jul. 2, 2021.
Advisory Action for U.S. Appl. No. 16/904,868 dated Jun. 15, 2022.
Advisory Action for U.S. Appl. No. 16/905,400 dated Feb. 16, 2022.
Advisory Action for U.S. Appl. No. 17/051,550 dated Sep. 8, 2023.
Advisory Action for U.S. Appl. No. 17/444,792 dated Aug. 25, 2023.
Advisory Action for U.S. Appl. No. 17/662,700 dated Jan. 30, 2023.
Corrected Notice of Allowability for U.S. Appl. No. 17/330,657 dated Dec. 9, 2021.
Final Office Action for U.S. Appl. No. 16/245,726 dated Nov. 25, 2022.
Final Office Action for U.S. Appl. No. 16/369,676 dated Aug. 31, 2023.
Final Office Action for U.S. Appl. No. 16/369,676 dated Dec. 5, 2022.
Final Office Action for U.S. Appl. No. 16/433,773 dated Oct. 25, 2022.
Final Office Action for U.S. Appl. No. 16/449,039 dated Aug. 1, 2022.
Final Office Action for U.S. Appl. No. 16/452,145 dated Mar. 25, 2022.
Final Office Action for U.S. Appl. No. 16/452,258 dated Jun. 14, 2022.
Final Office Action for U.S. Appl. No. 16/478,180 dated Jun. 22, 2022.
Final Office Action for U.S. Appl. No. 16/478, 180 dated May 31, 2023.
Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 10, 2022.
Final Office Action for U.S. Appl. No. 16/905,400 dated Dec. 9, 2021.
Final Office Action for U.S. Appl. No. 17/051,399 dated Mar. 9, 2023.
Final Office Action for U.S. Appl. No. 17/051,550 dated May 23, 2023.
Final Office Action for U.S. Appl. No. 17/051,585 dated Jul. 27, 2023.
Final Office Action for U.S. Appl. No. 17/444,792 dated Jun. 15, 2023.
Final Office Action for U.S. Appl. No. 17/446,256 dated Sep. 19, 2023.
Final Office Action for U.S. Appl. No. 17/448,811 dated Aug. 3, 2023.
Final Office Action for U.S. Appl. No. 17/451,345 dated May 3, 2023.
Final Office Action for U.S. Appl. No. 17/653,137 dated Sep. 21, 2023.
Final Office Action for U.S. Appl. No. 17/655,464 dated Sep. 1, 2023.
Final Office Action for U.S. Appl. No. 17/662,700 dated Sep. 30, 2022.
International Search Report and Written Opinion from International Application No. PCT/IB2021/057173 dated Nov. 5, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/033064 dated Aug. 31, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/033122 dated Aug. 31, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/040860 dated Oct. 2, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/041242 dated Nov. 17, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/041249 dated Oct. 2, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/042262 dated Oct. 14, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/043059 dated Oct. 6, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/044024 dated Nov. 12, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/046914 dated Dec. 1, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/055680 dated Dec. 15, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/057562 dated Jan. 27, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/061563 dated Feb. 19, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/065234 dated Apr. 12, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/067451 dated Mar. 25, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/067454 dated Mar. 29, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/067455 dated Mar. 26, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/015024 dated May 18, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/015787 dated May 27, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/023001 dated Jun. 21, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/024162 dated Jul. 8, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/026607 dated Jul. 29, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027061 dated Jul. 19, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027104 dated Jul. 6, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027314 dated Jul. 6, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027422 dated Aug. 12, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027425 dated Aug. 11, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027913 dated Jul. 12, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027917 dated Aug. 19, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/039866 dated Oct. 7, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/043893 dated Nov. 22, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/044699 dated Nov. 22, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/045188 dated Jan. 26, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/047536 dated Dec. 23, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/048211 dated Dec. 22, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/048661 dated Feb. 14, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/049404 dated Jan. 18, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/051456 dated Jan. 19, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/053593 dated Apr. 11, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/055515 dated Jan. 28, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/056566 dated Feb. 11, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/060993 dated Mar. 18, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/062440 dated Mar. 28, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/011108 dated Apr. 22, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/011281 dated Apr. 25, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/011419 dated Jun. 7, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/011421 dated Jun. 13, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/012794 dated May 3, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/014285 dated Sep. 28, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/014749 dated Sep. 28, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015026 dated Oct. 31, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015045 dated Sep. 9, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015073 dated Sep. 8, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015418 dated Nov. 11, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015420 dated Nov. 18, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015471 dated May 16, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015492 dated Apr. 26, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015781 dated May 6, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/016942 dated Jun. 8, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/018159 dated Dec. 12, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/018170 dated May 31, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/019254 dated Jun. 7, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/019480 dated Jun. 13, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/021103 dated Jun. 23, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/022111 dated Oct. 26, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/023594 dated Jul. 12, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/026667 dated Aug. 22, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/030685 dated Oct. 31, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/031032 dated Sep. 9, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/032424 dated Oct. 11, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/034457 dated Oct. 12, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/034744 dated Dec. 9, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/039018 dated Jan. 10, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/039022 dated Jan. 10, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/039711 dated Jan. 12, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/039714 dated Nov. 22, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/041085 dated Mar. 16, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/041688 dated Nov. 21, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/042719 dated Dec. 5, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/042725 dated Dec. 19, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/043818 dated Mar. 24, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/044107 dated Dec. 23, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/044208 dated May 8, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/044212 dated Jan. 20, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/044243 dated Feb. 24, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/049300 dated Jun. 6, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/050909 dated Jul. 24, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2023/012696 dated Jul. 6, 2023.
Issue Notification for U.S. Appl. No. 14/952,591 dated Jul. 28, 2021.
Issue Notification for U.S. Appl. No. 16/899,956 dated Mar. 29, 2023.
Issue Notification for U.S. Appl. No. 16/905,400 dated Nov. 30, 2022.
Issue Notification for U.S. Appl. No. 17/088,272 dated Jun. 15, 2022.
Issue Notification for U.S. Appl. No. 17/330,657 dated Jun. 22, 2022.
Issue Notification for U.S. Appl. No. 29/624,661 dated Aug. 4, 2021.
Non-Final Office Action for U.S. Appl. No. 16/245,726 dated Jan. 21, 2022.
Non-Final Office Action for U.S. Appl. No. 16/369,676 dated Mar. 31, 2022.
Non-Final Office Action for U.S. Appl. No. 16/433,773 dated Apr. 11, 2023.
Non-Final Office Action for U.S. Appl. No. 16/433,773 dated Apr. 21, 2022.
Non-Final Office Action for U.S. Appl. No. 16/449,039 dated Apr. 27, 2023.
Non-Final Office Action for U.S. Appl. No. 16/449,039 dated Dec. 8, 2021.
Non-Final Office Action for U.S. Appl. No. 16/452,145 dated Mar. 28, 2023.
Non-Final Office Action for U.S. Appl. No. 16/452,145 dated Sep. 28, 2021.
Non-Final Office Action for U.S. Appl. No. 16/452,258 dated Apr. 26, 2023.
Non-Final Office Action for U.S. Appl. No. 16/452,258 dated Sep. 28, 2021.
Non-Final Office Action for U.S. Appl. No. 16/478,180 dated Dec. 20, 2022.
Non-Final Office Action for U.S. Appl. No. 16/478,180 dated Oct. 22, 2021.
Non-Final Office Action for U.S. Appl. No. 16/899,956 dated Sep. 2, 2021.
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 15, 2023.
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Oct. 5, 2021.
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Apr. 27, 2022.
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Jul. 22, 2021.
Non-Final Office Action for U.S. Appl. No. 17/051,399 dated Aug. 18, 2023.
Non-Final Office Action for U.S. Appl. No. 17/051,550 dated Dec. 15, 2022.
Non-Final Office Action for U.S. Appl. No. 17/051,585 dated Mar. 29, 2023.
Non-Final Office Action for U.S. Appl. No. 17/179,116 dated Mar. 24, 2023.
Non-Final Office Action for U.S. Appl. No. 17/326,980 dated Jul. 11, 2023.
Non-Final Office Action for U.S. Appl. No. 17/330,657 dated Aug. 11, 2021.
Non-Final Office Action for U.S. Appl. No. 17/444,792 dated Feb. 10, 2023.
Non-Final Office Action for U.S. Appl. No. 17/446,256 dated Apr. 13, 2023.
Non-Final Office Action for U.S. Appl. No. 17/446,654 dated Sep. 8, 2023.
Non-Final Office Action for U.S. Appl. No. 17/448,811 dated Mar. 1, 2023.
Non-Final Office Action for U.S. Appl. No. 17/450,864 dated May 10, 2023.
Non-Final Office Action for U.S. Appl. No. 17/451,345 dated Dec. 7, 2022.
Non-Final Office Action for U.S. Appl. No. 17/451,354 dated May 3, 2023.
Non-Final Office Action for U.S. Appl. No. 17/453,260 dated Mar. 14, 2023.
Non-Final Office Action for U.S. Appl. No. 17/501,591 dated Apr. 25, 2023.
Non-Final Office Action for U.S. Appl. No. 17/646,771 dated Jul. 5, 2023.
Non-Final Office Action for U.S. Appl. No. 17/653,137 dated Apr. 7, 2023.
Non-Final Office Action for U.S. Appl. No. 17/655,464 dated Mar. 14, 2023.
Non-Final Office Action for U.S. Appl. No. 17/657,474 dated Sep. 12, 2023.
Non-Final Office Action for U.S. Appl. No. 17/661,090 dated Jul. 6, 2023.
Non-Final Office Action for U.S. Appl. No. 17/662,700 dated Jul. 22, 2022.
Non-Final Office Action for U.S. Appl. No. 17/663,330 dated Jun. 29, 2023.
Non-Final Office Action for U.S. Appl. No. 17/664,487 dated Jun. 8, 2023.
Non-Final Office Action for U.S. Appl. No. 18/139,523 dated Aug. 17, 2023.
Non-Final Office Action for U.S. Appl. No. 18/140,751 dated Sep. 14, 2023.
Non-Final Office Action for U.S. Appl. No. 29/741,751 dated Jan. 18, 2022.
Notice of Allowance for U.S. Appl. No. 14/952,591 dated Jul. 8, 2021.
Notice of Allowance for U.S. Appl. No. 16/245,726 dated Jul. 6, 2023.
Notice of Allowance for U.S. Appl. No. 16/449,039 dated Dec. 15, 2022.
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Apr. 19, 2022.
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Aug. 10, 2022.
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Dec. 1, 2022.
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Dec. 29, 2021.
Notice of Allowance for U.S. Appl. No. 16/905,400 dated Aug. 17, 2022.
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Aug. 5, 2021.
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Mar. 4, 2022.
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Nov. 24, 2021.
Notice of Allowance for U.S. Appl. No. 17/330,657 dated Mar. 16, 2022.
Notice of Allowance for U.S. Appl. No. 17/330,657 dated Nov. 26, 2021.
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Feb. 22, 2023.
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Jun. 30, 2023.
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Oct. 6, 2022.
Notice of Allowance for U.S. Appl. No. 17/662,700 dated Jul. 28, 2023.
Notice of Allowance for U.S. Appl. No. 17/662,700 dated Mar. 28, 2023.
Notice of Allowance for U.S. Appl. No. 17/663,046 dated Jan. 30, 2023.
Notice of Allowance for U.S. Appl. No. 18/299,788 dated Jul. 24, 2023.
Notice of Allowance for U.S. Appl. No. 29/741,751 dated Jun. 9, 2022.
Restriction Requirement for U.S. Appl. No. 16/433,773 dated Dec. 7, 2021.
Restriction Requirement for U.S. Appl. No. 17/051,600 dated Sep. 21, 2023.
Restriction Requirement for U.S. Appl. No. 17/326,980 dated Mar. 20, 2023.
Restriction Requirement for U.S. Appl. No. 17/446,256 dated Jan. 23, 2023.
Restriction Requirement for U.S. Appl. No. 17/645,821 dated Jul. 12, 2023.
Restriction Requirement for U.S. Appl. No. 17/646,771 dated Apr. 6, 2023.
Restriction Requirement for U.S. Appl. No. 17/657,474 dated Jun. 30, 2023.
Text Messages to Lorena Eckert Re Prototype PureWick Holder dated Apr. 16, 2022.
U.S. Appl. No. 14/625,469, filed Feb. 28, 2015.
U.S. Appl. No. 14/947,759, filed Nov. 20, 2015.
U.S. Appl. No. 14/952,591, filed Nov. 25, 2015.
U.S. Appl. No. 15/384,196 filed Dec. 19, 2016.
U.S. Appl. No. 16/245,726, filed Jan. 11, 2019.
U.S. Appl. No. 17/378,015, filed Jul. 16, 2021.
U.S. Appl. No. 17/394,055, filed Aug. 4, 2021.
U.S. Appl. No. 17/444,825, filed Aug. 10, 2021.
U.S. Appl. No. 17/446,256, filed Aug. 27, 2021.
U.S. Appl. No. 17/446,654, filed Sep. 1, 2021.
U.S. Appl. No. 17/447,123, filed Sep. 8, 2021.
U.S. Appl. No. 17/450,864, filed Oct. 14, 2021.
U.S. Appl. No. 17/451,345, filed Oct. 19, 2021.
U.S. Appl. No. 17/451,354, filed Oct. 19, 2021.
U.S. Appl. No. 17/453,260, filed Nov. 2, 2021.
U.S. Appl. No. 17/453,560, filed Nov. 4, 2021.
U.S. Appl. No. 17/461,036 dated Aug. 30, 2021.
U.S. Appl. No. 17/501,591, filed Oct. 14, 2021.
U.S. Appl. No. 17/595,747, filed Nov. 23, 2021.
U.S. Appl. No. 17/597,408, filed Jan. 5, 2022.
U.S. Appl. No. 17/597,673, filed Jan. 18, 2022.
U.S. Appl. No. 17/614,173, filed Nov. 24, 2021.
U.S. Appl. No. 17/631,619, filed Jan. 31, 2022.
U.S. Appl. No. 17/645,821, filed Dec. 23, 2021.
U.S. Appl. No. 17/646,771, filed Jan. 3, 2022.
U.S. Appl. No. 17/653,314, filed Mar. 3, 2022.
U.S. Appl. No. 17/653,920, filed Mar. 8, 2022.
U.S. Appl. No. 17/655,464, filed Mar. 18, 2022.
U.S. Appl. No. 17/657,474, filed Mar. 31, 2022.
U.S. Appl. No. 17/661,090, filed Apr. 28, 2022.
U.S. Appl. No. 17/662,700, filed May 10, 2022.
U.S. Appl. No. 17/663,046, filed May 12, 2022.
U.S. Appl. No. 17/664,487, filed May 23, 2022.
U.S. Appl. No. 17/664,914, filed May 25, 2022.
U.S. Appl. No. 17/749,340, filed May 20, 2022.
U.S. Appl. No. 17/754,736, filed Apr. 11, 2022.
U.S. Appl. No. 17/756,201, filed May 19, 2022.
U.S. Appl. No. 17/758,152, filed Jun. 29, 2022.
U.S. Appl. No. 17/758,316, filed Jul. 1, 2022.
U.S. Appl. No. 17/759,697, filed Jul. 28, 2022.
U.S. Appl. No. 17/878,268, filed Aug. 1, 2022.
U.S. Appl. No. 17/907,125, filed Sep. 23, 2022.
U.S. Appl. No. 17/912,147, filed Sep. 16, 2022.
U.S. Appl. No. 17/929,887, filed Sep. 6, 2022.
U.S. Appl. No. 17/930,238, filed Sep. 7, 2022.
U.S. Appl. No. 17/933,590, filed Sep. 20, 2022.
U.S. Appl. No. 17/996,064, filed Oct. 12, 2022.
U.S. Appl. No. 17/996,155, filed Oct. 13, 2022.
U.S. Appl. No. 17/996,253, filed Oct. 14, 2022.
U.S. Appl. No. 17/996,468, filed Oct. 18, 2022.
U.S. Appl. No. 17/996,556, filed Oct. 19, 2022.
U.S. Appl. No. 18/003,029, filed Dec. 22, 2022.
U.S. Appl. No. 18/006,807, filed Jan. 25, 2023.
U.S. Appl. No. 18/007,105, filed Jan. 27, 2023.
U.S. Appl. No. 18/041,109, filed Feb. 9, 2023.
U.S. Appl. No. 18/042,842, filed Feb. 24, 2023.
U.S. Appl. No. 18/043,618, filed Mar. 1, 2023.
U.S. Appl. No. 18/115,444, filed Feb. 28, 2023.
U.S. Appl. No. 18/134,857, filed Apr. 14, 2023.
U.S. Appl. No. 18/140,163, filed Apr. 27, 2023.
U.S. Appl. No. 18/140,751, filed Apr. 28, 2023.
U.S. Appl. No. 18/164,800, filed Feb. 6, 2023.
U.S. Appl. No. 18/198,464, filed May 17, 2023.
U.S. Appl. No. 18/246,121, filed Mar. 21, 2023.
U.S. Appl. No. 18/247,986, filed Apr. 5, 2023.
U.S. Appl. No. 18/259,626, filed Jun. 28, 2023.
U.S. Appl. No. 18/260,122, filed Jun. 30, 2023.
U.S. Appl. No. 18/260,391, filed Jul. 5, 2023.
U.S. Appl. No. 18/260,394, filed Jul. 5, 2023.
U.S. Appl. No. 18/263,800, filed Aug. 1, 2023.
U.S. Appl. No. 18/264,004, filed Aug. 2, 2023.
U.S. Appl. No. 18/265,736, filed Jun. 7, 2023.
U.S. Appl. No. 18/299,788, filed Apr. 13, 2023.
U.S. Appl. No. 18/335,579, filed Jun. 15, 2023.
U.S. Appl. No. 18/373,424, filed Sep. 27, 2023.
U.S. Appl. No. 18/376,274, filed Oct. 3, 2023.
U.S. Appl. No. 18/548,152, filed Aug. 28, 2023.
U.S. Appl. No. 18/549,387, filed Sep. 7, 2023.
U.S. Appl. No. 18/549,658, filed Sep. 8, 2023.
U.S. Appl. No. 18/553,625, filed Oct. 2, 2023.
U.S. Appl. No. 61/955,537, filed Mar. 19, 2014.
U.S. Appl. No. 62/082,279, filed Nov. 20, 2014.
U.S. Appl. No. 62/084,078, filed Nov. 25, 2014.
U.S. Appl. No. 62/414,963, filed Oct. 31, 2016.
U.S. Appl. No. 62/485,578, filed Apr. 14, 2017.
U.S. Appl. No. 62/853,279, filed May 28, 2019.
U.S. Appl. No. 62/864,656, filed Jun. 21, 2019.
U.S. Appl. No. 62/876,500, filed Jul. 19, 2019.
U.S. Appl. No. 62/877,558, filed Jul. 23, 2019.
U.S. Appl. No. 62/883,172, filed Aug. 6, 2019.
U.S. Appl. No. 62/889,149 filed Aug. 20, 2019.
U.S. Appl. No. 62/923,279, filed Oct. 18, 2019.
U.S. Appl. No. 62/926,767, filed Oct. 28, 2019.
U.S. Appl. No. 62/935,337, filed Nov. 14, 2019.
U.S. Appl. No. 62/938,447, filed Nov. 21, 2019.
U.S. Appl. No. 62/949,187 filed Dec. 17, 2019.
U.S. Appl. No. 62/956,756, filed Jan. 3, 2020.
U.S. Appl. No. 62/956,767, filed Jan. 3, 2020.
U.S. Appl. No. 62/956,770, filed Jan. 3, 2020.
U.S. Appl. No. 62/967,158, filed Jan. 26, 2020.
U.S. Appl. No. 62/967,977, filed Jan. 30, 2020.
U.S. Appl. No. 62/991,754, filed Mar. 19, 2020.
U.S. Appl. No. 63/008,112, filed Apr. 10, 2020.
U.S. Appl. No. 63/030,685, filed May 27, 2020.
U.S. Appl. No. 63/047,374, filed Jul. 2, 2020.
U.S. Appl. No. 63/067,542, filed Aug. 19, 2020.
U.S. Appl. No. 63/073,545, filed Sep. 2, 2020.
U.S. Appl. No. 63/073,553, filed Sep. 2, 2020.
U.S. Appl. No. 63/094,498, filed Oct. 21, 2020.
U.S. Appl. No. 63/094,646, filed Oct. 21, 2020.
U.S. Appl. No. 63/109,066, filed Nov. 3, 2020.
U.S. Appl. No. 63/109,084, filed Nov. 3, 2020.
U.S. Appl. No. 63/112,417, filed Nov. 11, 2020.
U.S. Appl. No. 63/119,161, filed Nov. 30, 2020.
U.S. Appl. No. 63/124,271, filed Dec. 11, 2020.
U.S. Appl. No. 63/133,892, filed Jan. 5, 2021.
U.S. Appl. No. 63/134,287, filed Jan. 6, 2021.
U.S. Appl. No. 63/134,450, filed Jan. 6, 2021.
U.S. Appl. No. 63/134,631, filed Jan. 7, 2021.
U.S. Appl. No. 63/134,632, filed Jan. 7, 2021.
U.S. Appl. No. 63/134,754, filed Jan. 7, 2021.
U.S. Appl. No. 63/138,878, filed Jan. 19, 2021.
U.S. Appl. No. 63/146,946, filed Feb. 8, 2021.
U.S. Appl. No. 63/147,013, filed Feb. 8, 2021.
U.S. Appl. No. 63/147,299, filed Feb. 9, 2021.
U.S. Appl. No. 63/148,723, filed Feb. 12, 2021.
U.S. Appl. No. 63/150,640, filed Feb. 18, 2021.
U.S. Appl. No. 63/154,248, filed Feb. 26, 2021.
U.S. Appl. No. 63/155,395, filed Mar. 2, 2021.
U.S. Appl. No. 63/157,007, filed Mar. 5, 2021.
U.S. Appl. No. 63/157,014, filed Mar. 5, 2021.
U.S. Appl. No. 63/159,142, filed Mar. 10, 2021.
U.S. Appl. No. 63/159,186, filed Mar. 10, 2021.
U.S. Appl. No. 63/159,210, filed Mar. 10, 2021.
U.S. Appl. No. 63/165,273, filed Mar. 24, 2021.
U.S. Appl. No. 63/165,384, filed Mar. 24, 2021.
U.S. Appl. No. 63/171,165, filed Apr. 6, 2021.
U.S. Appl. No. 63/172,975, filed Apr. 9, 2021.
U.S. Appl. No. 63/181,695, filed Apr. 29, 2021.
U.S. Appl. No. 63/191,558, filed May 21, 2021.
U.S. Appl. No. 63/192,274, filed May 24, 2021.
U.S. Appl. No. 63/192,289, filed May 24, 2021.
U.S. Appl. No. 63/193,235, filed May 26, 2021.
U.S. Appl. No. 63/193,406, filed May 26, 2021.
U.S. Appl. No. 63/193,891, filed May 27, 2021.
U.S. Appl. No. 63/208,262, filed Jun. 8, 2021.
U.S. Appl. No. 63/214,551, filed Jun. 24, 2021.
U.S. Appl. No. 63/214,570, filed Jun. 24, 2021.
U.S. Appl. No. 63/215,017, filed Jun. 25, 2021.
U.S. Appl. No. 63/228,244, filed Aug. 2, 2021.
U.S. Appl. No. 63/228,252, filed Aug. 2, 2021.
U.S. Appl. No. 63/228,258, filed Aug. 2, 2021.
U.S. Appl. No. 63/230,894, filed Aug. 9, 2021.
U.S. Appl. No. 63/230,897, filed Aug. 9, 2021.
U.S. Appl. No. 63/238,457, filed Aug. 30, 2021.
U.S. Appl. No. 63/238,477, filed Aug. 30, 2021.
U.S. Appl. No. 63/241,328, filed Sep. 7, 2021.
U.S. Appl. No. 63/241,562, filed Sep. 8, 2021.
U.S. Appl. No. 63/241,564, filed Sep. 8, 2021.
U.S. Appl. No. 63/241,575, filed Sep. 8, 2021.
U.S. Appl. No. 63/246,972, filed Sep. 22, 2021.
U.S. Appl. No. 63/247,375, filed Sep. 23, 2021.
U.S. Appl. No. 63/247,478, filed Sep. 23, 2021.
U.S. Appl. No. 63/247,491, filed Sep. 23, 2021.
U.S. Appl. No. 63/299,208, filed Jan. 13, 2022.
U.S. Appl. No. 63/308,190, filed Feb. 9, 2022.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 2, Mar. 29, 2022.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 3, Mar. 30, 2022.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 4, Mar. 31, 2022.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 5, Apr. 1, 2022.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 1, Mar. 28, 2022.
“AMXD Control Starter Kit”, Omni Medical Systems, Inc., 1 page.
“AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical, Jan. 11, 2010, 10 pages.
“AMXDmax Development History 2002-2014”, Omni Medical Systems, Inc., 2 pages.
“Combat Force Multiplier in Flight Bladder Relief Cockpit Essential Equipment Brochure”, Omni Medical, 20 pages.
“External Urine Management for Female Anatomy”, https://www.stryker.com/us/en/sage/products/sage-primafit.html, Jul. 2020, 4 pages.
“GSA Price List”, Omni Medical, Apr. 2011, 2 pages.
“High Absorbancy Cellulose Acetate Electrospun Nanofibers for Feminine Hygiene Application” , https://www.sciencedirect.com/science/article/abs/pii/S2352940716300701?via%3Dihub , Jul. 2016, 3 pages.
“How is Polypropylene Fiber Made”, https:www.yarnsandfibers.com/textile-resources/synthetic-fibers/polypropylene-fiber/polypropylene-fiber-production-raw-materials/how-is-polypropylene-fiber-made/ last accessed 2020, Oct. 7, 2020, 3 pages.
“Hydrogel properties of electrospun polyvinylpyrrolidone and polyvinylpyrrolidone/poly(acrylic acid) blend nanofibers”, https://pubs.rsc.org/en/content/articlelanding/2015/ra/c5ra07514a#!divAbstract, 2015, 5 pages.
“Letter to Mark Harvie of Omni Measurement Systems”, Department of Veterans Affairs, Nov. 1, 2007, 11 pages.
“Making Women's Sanitary Products Safer and Cheaper”, https://www.elsevier.com/connect/making-womens-sanitary-products-safer-and-cheaper, Sep. 2016, 10 pages.
“Novel Nanofibers Make Safe and Effective Absorbent for Sanitary Products”, https://www.materialstoday.com/nanomaterials/news/nanofibers-make-safe-and-effective-absorbent/, Oct. 2016, 3 pages.
“Revised AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical Systems, Oct. 8, 2019, 52 pages.
“Rising Warrior Insulated Gallon Jug Cover”, https://www.amazon.com/Rising-Warrior-Insulated-Sleeve, 2021, 2 pages.
“Urine Bag Cover-Catheter Bag Cover 2000 ml Volume-Medline Style-Multiple Sclerosis-Spine Injury-Suprapublic Catheter-Bladder Incontinence”, https://www.etsy.com/listing/1142934658/urine-bag-cover-caatheter-bag-cover-2000, 2022, 1 page.
“Vinyl Dust Cover, Janome #741811000, Janome, Sewing Parts Online”, https://www.sewingpartsonline.com/vinyl-dust-cover-janome-74181000, 2020, 2 pages.
Ali, “Sustainability Assessment: Seventh Generation Diapers versus gDiapers”, The University of Vermont, Dec. 6, 2011, pp. 1-31.
Autumn, et al., “Frictional adhesion: a new angle on gecko attachment”, The Journal of Experimental Biology, 2006, pp. 3569-3579.
Cañas, et al. , “Effect of nano- and micro-roughness on adhesion of bioinspired micropatterned surfaces” , Acta Biomaterialia 8 , 2012, pp. 282-288.
Chaudhary, et al., “Bioinspired dry adhesive: Poly(dimethylsiloxane) grafted with poly(2-ethylhexyl acrylate) brushes”, European Polymer Journal, 2015, pp. 432-440.
Dai, et al., “Non-sticky and Non-slippery Biomimetic Patterned Surfaces”, Journal of Bionic Engineering, Mar. 2020, pp. 326-334.
Espinoza-Ramirez, “Nanobiodiversity and Biomimetic Adhesives Development: From Nature to Production and Application”, Journal of Biomaterials and Nanobiotechnology, pp. 78-101, 2019.
Hwang, et al., “Multifunctional Smart Skin Adhesive Patches for Advanced Health Care”, Adv. Healthcare Mater, 2018, pp. 1-20.
Jagota, et al., “Adhesion, friction, and compliance of bio-mimetic and bio-inspired structured interfaces”, Materials Science and Engineering, 2011, pp. 253-292.
Jeong, et al., “A nontransferring dry adhesive with hierarchical polymer nanohairs”, PNAS, Apr. 7, 2009, pp. 5639-5644.
Jeong, et al., “Nanohairs and nanotubes: Efficient structural elements for gecko-inspired artificial dry adhesives”, Science Direct, 2009, pp. 335-346.
Karp, et al., “Dry solution to a sticky problem”, Nature, 2011, pp. 42-43.
Lee, et al., “Continuous Fabrication of Wide-Tip Microstructures for Bio-Inspired Dry Adhesives via Tip Inking Process”, Journal of Chemistry, Jan. 2, 2019, pp. 1-5.
Merriam-Webster Dictionary, “Embed Definition & Meaning”, https://www.merriam-webster.com/dictionary/embed last accessed Aug. 3, 2023, 2003.
Parness, et al., “A microfabricated wedge-shaped adhesive array displaying gecko-like dynamic adhesion, directionality”, J.R. Soc. Interface, 2009, pp. 1223-1232.
Pieper, et al., “An external urine-collection device for women: A clinical trial”, Journal of ER Nursing, vol. 20, No. 2, Mar./Apr. 1993, pp. 51-55.
Tsipenyuk, et al., “Use of biomimetic hexagonal surface texture in friction against lubricated skin”, Journal of The Royal Society—Interface, 2014, pp. 1-6.
Vinas, “A Solution For An Awkward—But Serious—Subject”, http://www.aero-news.net/index.cfm?do=main.textpost&id=69ae2bb1-838b-4098-a7b5-7flbb2505688 last accessed Feb. 8, 2021.
Related Publications (1)
Number Date Country
20210236323 A1 Aug 2021 US
Provisional Applications (1)
Number Date Country
62665321 May 2018 US